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We are using the feline immunodeficiency virus (FIV)-infected cat to model
HIV mother-to-child-transmission (MTCT). Vertical transmission of either virus
may result not only in infected offspring, but also failed pregnancy.In HIV
infections, maternal hematological and virological parameters predict MTCT.We
hypothesized that such parameters would likewise be predictors of FIV vertical
transfer. We inoculated ten cats with FIV-B-2542; 10 cats were uninoculated.
Cats were allowed to breed naturally. Fetuses were delivered at approximately
week 3 (early) gestation by cesarean section. Fetal and placental tissues were
collected.Blood samples were collected from the day of inoculation through
delivery. We quantified CD4:CD8 T cell ratios, proviral load, and plasma viremia,
and monitored seroreactivity to FIV proteins in longitudinal sera from both groups
of cats. We documented clinical and reproductive outcome. The infected group
produced reduced litter size and more failed pregnancies; CD4:CD8 ratios were
depressed by 3.5 months p.i.Proviral DNA was detected in 14 of 14 (100%)
placentas tested and 12 of 14 (86%) fetuses. However, the parameters assessed
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were not predictive of reproductive outcome and suggested a role for placental
immunopathology in compromised pregnancy.Regulatory T cells (Treg) are antiinflammatory and essential in maintaining pregnancy.Th17 cells are proinflammatory and associated with pregnancy failure. The activation of these cell
populations is regulated by the cytokines TGF-β and IL-6. We hypothesized that
placental immunology may result from altered dynamics of these cell
populations.Using immunofluorescence confocal microscopy to measure Treg
and Th17 markers FoxP3 and RORγ, respectively, we quantified these cells in
placental specimens from FIV-infected and control cats at early and late (week 8)
gestation.Significantly higher levels of RORγ were measured in FIV-infected
placentas at early pregnancy; these cells co-localized at the maternal-fetal
interface. We quantified the expression of Treg immunomodulators by
quantitative PCR, noting higher expression of TGF-β in infected queens.A
positive correlation of RORγ with IL-6 occurred in control placentas, as predicted,
but not in infected placentas.Collectively, the data suggest that an inflammatory
placental microenvironment at early pregnancy in infected queens may result, in
part, from dysregulation of the Treg/Th17 balance.
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CHAPTER I
REVIEW OF PERTINENT LITERATURE
Women are the fastest-growing newly HIV-infected population in the
United States. Since the onset of the epidemic in 1985, the percentage of
women diagnosed with HIV increased from ~7% to 25% (CDC, 2009). In 2009,
42,959 people were infected with HIV in 40 U.S. states and 5 U.S. dependent
areas; 9,973 were women and 166 were children under the age of 13. Of the
166 children, 131 of those cases (79%) were a result of perinatal transmission
(CDC, 2009). Effective antiretroviral therapy in the U.S. has reduced mother to
child transmission (MTCT) to approximately 2% of pregnancies, and pediatric
AIDS represents about 1% of all AIDS cases (CDC, 2009). Globally, there are
33.3 million people living with HIV, 15.9 million are women, and 370,000 are
children (UNAIDS, 2010). MTCT is the most important means of pediatric
infection, accounting for more than 90% of infections (CDC, 2009). The number
of new pediatric infections has reached 2.6 million (UNAIDS, 2010). In addition,
HIV infection of pregnant women often results in poor outcome, including lowbirth-weight babies, preterm delivery, and enhanced incidence of spontaneous
abortions (D'Ubaldo et al., 1998; Kumar, Uduman, and Khurranna, 1995;
Langston et al., 1995).
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The FIV-infected Cat as a Model for HIV Pathogenesis
The FIV-infected cat is an excellent small animal model for HIV
pathogenesis and perinatal transmission. FIV and HIV-1 share many similar
characteristics as members of the family Retroviridae, genus Lentivirus. A
spherical to ellipsoid core encapsidates a dimeric, positive-stranded,
polyadenylated RNA genome 9,200 base pairs in length.The genome
organization is similar to other lentiviruses with three large open reading frames
(ORF), gag, pol, and env. Core proteins encoded in the gag ORF share
antigenic determinants with other members of this genus as a result of the high
degree of genetic conservation in the gag region (Olmsted et al., 1989). Amino
acid alignments between the highly conserved gag regions of FIV and HIV-1
reveal 40% homology. There are common accessory genes, viral infectivity
factor (vif), rev response element (rev), and OrfA involved in regulation of viral
gene expression and viral replication.
A difference between the two viruses is host cell tropism. FIV has a
broader cell tropism in vivo, including both CD4+ and CD8+ T cells,
monocytes/macrophages, B cells, astrocytes, and microglia (Brown et al., 1991;
Brunner and Pedersen, 1989; Dow, Dreitz, and Hoover, 1992; English et al.,
1993). The primary binding receptor utilized by FIV is CD134, an activation
marker on T cells (de Parseval et al., 2004; Shimojima et al., 2004). Both FIV
and HIV use the chemokine receptor CXCR4 as a co-receptor for entry into the
host cell (Richardson et al., 1999; Willett, Cannon, and Hosie, 2002; Willett et al.,
1997).
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Natural infection differs between the two viruses.The seroprevalence of
FIV ranges from 3-15% of domestic cats to nearly 100% of some wild felid
species. FIV is mainly transmitted through bite wounds. Therefore, in domestic
cats, infection is most frequent in free-roaming males. The potential for bite
transmission was confirmed by the detection of antigen in saliva (Bendinelli et al.,
1995).
Clinical Consequences of Infection
The clinical outcome of FIV infection in the cat closely parallels that
occurring in the HIV-infected human.FIV-induced disease progresses in stages
similar to those occurring in the HIV-infected human (Bendinelli et al., 1995). The
acute phase of disease occurs weeks to months after initial infection and is
manifested as mild symptoms that typically are not fatal. On a few occasions
there have been reports of deaths at this stage of infection, but a causal
relationship between viral infection and the deaths of the animals was not
determined. Symptoms that may occur during the acute phase include
lymphadenopathy, mild pyrexia, dullness, depression, anorexia, acute diarrhea,
conjunctivitis, dermatitis, gingivitis, and mild upper respiratory symptoms.
Progression of the disease leads to the asymptomatic phase in which the
symptoms diminish, and the disease remains clinically silent for a period up to 2
years. The silencing of symptoms during the asymptomatic phase does not
correspond to viral clearance, as the virus can be isolated from peripheral blood
mononuclear cells, plasma, and saliva during this stage. The AIDS-related
complex (ARC) stage occurs with the start of chronic secondary infections of the
3

oral cavity, upper respiratory tract, and other body sites. Symptoms occurring
during this phase include weight loss, lymphadenopathy, fever, hematologic
abnormalities, alopecia, and pruritus. Some disorders of the nervous system and
kidneys may appear. Feline AIDS is characterized by an increase in the severity
of the chronic secondary infections. Neoplastic and neurologic disorders may
occur, and unlike the ARC stage, incurable opportunistic infections of the oral
cavity and upper respiratory tract caused by Staphylococcussp, Pseudomonas
sp., Streptococcuscanis, and other aerobic and anaerobic bacteria may occur.
Progressive weight loss and anemia occur, followed by a rapid clinical decline
which can cause death in less than a year.
Viral Load in FIV Infection
High viral RNA loads frequently are detected in peripheral blood
mononuclear cells, serum, and plasma during the acute and terminal stages of
an FIV infection, while viral loads decline during the asymptomatic phase. Peak
viremia may occur at 1-3 weeks post infection(Diehl et al., 1995; Diehl et al.,
1996). Disease progression depends on the immune competence of each
individual animal; therefore, cats that have rapidly-developing immunodeficiency
have a plasma viral RNA load 1 to 2 logs higher than those cats that can
withstand the disease for long periods of time (Diehl et al., 1995).
In some cases where FIV-specific antibody reactivity was compared to
PCR, animals were seropositive but PCR negative due to the amount of
fluctuation in viremia in the early stages post infection. Fluctuation in proviral
loads occurring during the course of infection were ascribed to a decrease in
4

infected CD4+ T cells targeted by cytolytic T lymphocytes (CTLs) and to
apoptosis (Ohkura et al., 1997).
The timing of virus expression in animal tissues was evaluated by
comparing tissues for the presence of FIV provirus and viral RNA. Provirus was
detected in various lymphoid tissues 35 days post infection, but viral RNA was
found in the thymus only after 70 days post infection (Ohkura et al., 1997).
Infected cells emerging from infected primary lymphoid tissues replenish the
supply of infected cells in the peripheral circulation, thereby maintaining provirus
within the circulatory system.
Maternal Correlates of Lentiviral Vertical Transmission
Maternal virological and hematological factors including plasma viremia
and CD4+ T cell counts influence HIV vertical transfer. HIV-1 targets CD4+T
cells, dendritic cells, and monocytes/macrophages. The viral outer-envelope
glycoprotein gp120 binds to CD4+ (primary receptor) and a cell specific
chemokine receptor (co-receptor), leading to fusion of the viral and cellular
membranes and entry of the virus into the targeted cell (Douek et al., 2002). The
migratory nature of these cell populations may be responsible for transport of the
virus to other tissues.
Plasma viremia is essential to vertical transmission. In one case study, a
woman became seropositive for HIV at 34 weeks pregnancy with a viral load
402,000 copies/ml at this time. She was treated with antiretroviral drugs, which
decreased the viral loadto 744 copies/ml by week 38. Although her plasma
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viremia was still at this level at 8 days prior to delivery, her baby was infected at
delivery(Moses et al., 2008).
Phuapradit et al. (1999) documented transmission of HIV-1 in one out of
nine fetuses with a maternal viral load greater than or equal to 100,000 copies/ml
compared to one out of thirty-two with less than 100,000 copies/ml. High virus
titer and low CD4+ count predispose vertical transmission (Blanche et al., 1994;
Tovo et al., 1994;Weiser et al., 1994). Assessing maternal CD4/CD8 T-cell ratios
is an effective method for predicting potentially infected infants (Read, 2007;
Shearer et al., 2007). A South African study showed risk of MTCT by 8 weeks in
a population of 962 infants correlating with maternal CD4+ T cell counts (Rollins
et al., 2007). Maternal CD4+ T cell counts of 500 cell/ml or more correlated with
38 (9%) infections, 201-500 cell/ml correlated with 76 (18%) infections, and 200
cell/ml or less correlated with 27 (25%) infections (Rollins et al., 2007).
Similar to HIV infections, CD4+ T cell counts in FIV infected cats are
inversely related to viral load. O’Neil, et al. (1996) evaluated CD4+ counts and
vertical transmission rate. A transmission rate of 88% was seen in queens with
CD4+ counts less than 200 cells per ul. Queens with higher counts showed a
39% transmission rate (O'Neil, Burkhard, and Hoover, 1996). In both HIV and
FIV infections, MTCT seems to increase when CD4+ T-cell counts fall below 200
cell/ul(O'Neil, Burkhard, and Hoover, 1996).
Hematological Dynamics of Viral Infection
Humans infected with HIV show a depletion of CD4+ T cells as a
consequence of virus-mediated destruction of these cells (Deeks et al., 2004;
6

McCune, 2001; Yates et al., 2007). At each stage of infection, HIV-specific
memory CD4+ T cells contain more HIV proviral DNA than other memory CD4+
T cells (Douek et al., 2002), potentially explaining the selective loss of these cells
during infection and consequent loss of immunological control of HIV infection.
Activated memory T cells, especially those expressing CCR5, are much more
vulnerable to lysis by cytotoxic T lymphocytes than resting memory T cells that
are CCR5-, leading to a persistent HIV infection (Liu and Roederer, 2007).
During early HIV infection, CD4+ and CD8+ T cell activation correlates with the
level of viremia, and the rate of CD4+ T cell depletion can be predicted by the
activation of CD8+ T cells (Deeks et al., 2004). Infected individuals may develop
AIDS rapidly when higher plasma viral loads are present due to the inability of
the immune system to replenish destroyed CD4+ lymphocytes (John W. Mellors,
1997).
Maternal CD4+ counts were found to be inversely related to HIV-1 in the
cervix, vagina, and breast milk. FIV infects many cell types including CD4+ and
CD8+ T lymphocytes, B lymphocytes, and macrophages (Frey, Hoover, and
Mullins, 2001).FIV provirus was detected in peripheral blood CD4+ and CD8+ T
cells as early as two weeks post infection (Dean et al., 1996).
A feature of infection is the depletion of circulating CD4+ T cells in two
different phases of the infection, the first being the primary phase where the
largest decline is detected. Shortly thereafter, the depletion becomes more
gradual (Bendinelli et al., 1995). Activated CD4+ T cells are depleted largely
during the acute phase of an FIV infection due to the expression of the receptor
CD134 (Shimojima et al., 2004; Willett, Cannon, and Hosie, 2003). As CD4+ T
7

cells are depleted, FIV modifies the immune system by activating more CD8+T
cells (Paillot et al., 2005).
FIV infections result in a distinctly inverted CD4:CD8 T cells ratio with the
depletion of CD4+ cells (Garg, Joshi, and Tompkins, 2004). Song and
colleagues (1992) reported that the CD4:CD8 T cell ratio in peripheral blood
mononuclear cells dropped below 1.0 by twenty weeks of infection and remained
low throughout the course of infection(Song et al., 1992). An inversion of the T
cell ratio is further mediated by the differentiation of CD8+ cells into TNF-α+cells
which mark themselves for apoptosis, die, and eventually re-establish their
population, while CD4+ T cells apparently are not readily replenished (Paillot et
al., 2005). Garg et al (2004) reported that apoptosis in activated peripheral blood
mononuclear cells is dependent upon binding of the envelope glycoprotein to
CXCR4, but not CD134, and that fusion induced by gp41 is essential to this
process.
Rate and Timing of MTCT
Vertical transmission of HIV occurs mainly at late gestation and/or at the
time of delivery, corresponding to rupture of maternal membranes (Fang et al.,
1995; Garcia et al., 1999;Phuapradit et al., 1999). However, early in utero
transmission was indicated by the detection of HIV in 8 week fetal tissue
(Courgnaud et al., 1991; Lewis et al., 1990) and by the frequent detection of the
virus in tissues from electively-aborted, 16- to 24- week fetuses (fetuses less
than 16 weeks were not examined) from asymptomatic, HIV-infected women
(Courgnaud et al., 1991). Langston, et al (Langston et al., 1995) detected HIV in
8

four miscarried fetuses that were 18 weeks gestation and younger and in three
fetuses that were older than 32 weeks gestation. Collectively, these data
indicate that early in utero transmission may be more frequent than recognized.
Rogers and Hoover (Rogers and Hoover, 1998) evaluated the timing of
transplacental transmission of FIV-B-2542 in chronically-infected queens,
reporting that in utero infection rate increased with progressing gestational age.
The virus was detected in 0/16 kittens delivered at 3 weeks gestation, 1/19 (5%)
kittens delivered at 5 weeks gestation, 6/16 (38%) kittens delivered at 7 weeks
gestation, and 9/15 (60%) kittens delivered at nine weeks gestation. Virus load
and hematological parameters in the queens did not vary substantially with
gestational age, suggesting that placental or fetal maturation may predispose the
timing of in utero infection. Using the same isolate, we detected proviral FIV in at
least one tissue from 21 of 22 offspring delivered by cesarean section from
infected queens during the eighth week of gestation, a 95% in utero transmission
rate. Fourteen of 15 placentas were virus positive, and provirus was frequently
detected in blood, brain, liver, bone marrow, spleen, and thymus (Weaver et al.,
2005a). Using cats inoculated with either FIV-B-2542 or FIV-AB-2771 a
minimum of four months prior to breeding, O’Neil, et al. (O'Neil, Burkhard, and
Hoover, 1996) detected FIV infection in 42 of 83 fetuses (51%) at term delivery
and in 7 foster-nursed kittens by 6 months of age. The latter group of kittens
apparently wasinfected late in gestation or during delivery. At 9 weeks gestation,
in utero transmission rates of 67% (8 of 12 fetuses) and 91% (10 of 11 fetuses)
occurred in cats infected with FIV-A-Pet and FIV-C-Pgmr, respectively. Viral load
and tissue distribution varied with different isolates, and viral sequestration in
9

fetal tissues frequently occurred in the absence of detectable viremia. Infected
fetuses frequently were detected even where virus could not be detected in the
placenta (Rogers and Hoover, 2002).
Reproductive Outcome in Lentiviral Infections
HIV infection may contribute to compromised pregnancy and reproductive
failure. The CDC reported an estimated six to seven thousand HIV-positive
women give birth each year in the U.S. (CDC, 2008). Up to 370 HIV-infected
infants are born in the U.S. with 5000 cumulative deaths from perinatally
acquired AIDS (CDC, 2008). Evaluating miscarriage rates in a cohort of HIVinfected women from the United States, spontaneous fetal loss occurred in 14 of
124 pregnancies (11.3%) ranging from 8 to 32 weeks gestation, approximately
three times the rate of loss in the general population at comparable gestational
stages(Langston et al., 1995). HIV was detected in 7 of 12 (58%) of these
aborted fetal tissues. A retrospective study of HIV-infected Italian women
revealed a 67% increase in the risk of spontaneous abortions in that group
(D'Ubaldo et al., 1998). Significantly increased rates of spontaneous abortion
and other indicators of compromised pregnancy were noted in a group of HIVinfected Indian women(Kumar, Uduman, and Khurranna, 1995). In a population
of 1449 HIV- infected South African pregnant women, there were 13 (0.90%)
spontaneous abortions, 5 (0.35%) antenatal deaths, and 63 (4..35%) stillbirths
(Rollins et al., 2007). HIV infection is associated with low-birth-weight babies
(Goldstein, 2000) and pre-term delivery (Anderson, 2001). Pre-term delivery
appears to correlate with immune suppression (less than 14% CD4+ T cells) in
10

HIV-infected women (Cohan, 2003). No differences in reproductive outcome
between HIV seropositive and negative womenwere reported in other
studies(Massad et al., 2004).
FIV infection in the pregnant queen may result in pregnancy perturbation.
In our study of vertical transmission using FIV-B-2542-infected queens, average
litter sizes delivered during the eighth week of gestation were 2.7 kittens/litter and
3.8 kittens/litter in FIV-infected and control queens, respectively (Weaver et al.,
2005b). Fetal non-viability was 60% (15 of 25 offspring) in the infected group and
3.2% (1 of 31 offspring) in the control group. Fetal resorptions and fetuses
developmentally arrested early in pregnancy comprised the non-viable offspring,
indicating that perturbation occurred early in pregnancy. In a separate study
using FIV-B-2542, 11 cats were infected that produced 25 viable and 18 nonviable kittens (Allison and Hoover, 2003). Arrested fetal development, stillbirth,
and abortion associated with in utero FIV-CSU-2771 infections were reported
(O'Neil et al., 1995). Nine of 17 of the kittens (53%) were either stillborn or dead
within 48 hours of birth in that study. O’Neil et al. infected a group of 13 queens
with either of two clinical isolates FIV-B-2542 and FIV-AB-2771. From the 13
queens, 83 kittens were produced with 51% of the kittens testing FIV positive at
birth (O'Neil, Burkhard, and Hoover, 1996). Viability was 70% with 58 kittens and
non-viability was 30% with 25 non-viable kittens (O'Neil, Burkhard, and Hoover,
1996). Collectively, these data demonstrate the deleterious effect of FIV
infection on pregnancy and indicate that compromised pregnancy in the FIVinfected cat may parallel pregnancy loss that occurs in HIV-infected women.
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The immunology of pregnancy
The phenomenon of immune tolerance to the fetal allograft is not fully
understood. Nobel Laureate Peter Medawar began the field of pregnancy
immunology in 1953 with three hypotheses in an attempt to explain the
suppression of the maternal immune system and tolerance to the fetus: (a)
physical separation of mother and fetus; (b) antigenic immaturity of the fetus; and
(c) immunologic inertness of the mother(Medawar, 1953). Wegmann and
Raghupathy refuted these hypotheses in 1980 with the Th1/Th2 paradigm
(Raghupathy, 1997; Wegmann et al., 1993). The paradigm established the idea
that up regulation of Th2 anti-inflammatory cytokines and suppression of Th1
pro-inflammatory cytokines correlates with a successful pregnancy (Lim et al.,
2000; Raghupathy, 1997; Raghupathy, 2001; Raghupathy et al., 1999;
Raghupathy et al., 2000).
Immunoregulatory cytokines produced at the maternal-fetal interface are
essentialfor a successful pregnancy, and this site favors, but is not limited toTh2
responses (Mellor, 2000). Suppression of the inflammatory cytokines is
necessary in the early stages of pregnancy because Th1 cytokines induce
placental inflammation, leading to pre-eclampsia, pre-term delivery, and/or
spontaneous abortion (Lim et al., 2000; Makhseed et al., 2000;Makhseed et al.,
2001). Currently, the paradigm is challenged with new evidence revealing the
contributions of innate and adaptive immunity to regulatory mechanisms
essential for pregnancy (Chaouat et al., 2004; Lim et al., 2000; Saito et al., 2010;
Sargent, Borzychowski, and Redman, 2006; Trowsdale and Betz, 2006).

12

The inflammatory cytokine IL-18, which causes increased IFN-γproduction
by T cells and NK cells, was expressed at lower levels in abortion prone mice
(Ostojic et al., 2003).Other murine studies show both inflammatory and antiinflammatory cytokines present at the maternal-fetal interface (Zourbas et al.,
2001)and lower inflammatory cytokine levels of IL-12 in the decidual and
peripheral leukocytes from spontaneous abortion patients as compared to
patients experiencing a normal pregnancy (Zenclussen, 2006). Mellor and Munn
stated that the uterus may be “preconditioned” to acceptthe fetal allograft as
dramatic changes in cytokine balance are likely to be minimal at mucosal
surfaces and lymph nodes draining the maternal-fetal unit (Mellor, 2000).
The mechanisms of transplacental transmission and pregnancy
perturbationassociated with lentiviral infections are unclear. Placental
inflammation in HIV-infected women was hypothesized to contribute to
transplacental transfer as a result of abnormal cytokine expression (Shearer et
al., 1997). Disruption of cytokine expression in placental trophoblasts caused by
the virus may contribute to inflammation of the placenta and transplacental
transfer (Shearer et al., 1997).
Using the FIV-infected cat model, parameters of lentiviral placental
inflammation can be analyzed. We found no significant differences in the
expression of placental inflammatory or anti-inflammatory cytokines between
infected and control cats at week eight gestation (Weaver et al., 2005a).
However, in nonviable pregnancies, inflammatory cytokine expression was
increased (Weaver et al., 2005a). In addition, expression of CXCR4 and CD134
was detected at differing levels in infected and control populations of viable and
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nonviable fetuses (Scott et al., 2008). The surface expression of these markers
suggested that cells bearing these receptors play a role in pregnancy
maintenance. Recently, we found evidence of a significant decrease in the
number of regulatory T cells in infected versus control whole placental tissue at
early pregnancy (Lockett et al., 2010). The inflammatory cytokine IL-6 was also
found to be significantly up regulated in whole placental tissues at early
pregnancy (Scott et al., 2011). Our collective data support a pro-inflammatory
placental microenvironment at early pregnancy.
Regulatory T cells and pregnancy
Natural regulatory T cells were first characterized in mice when a small
percentage ofCD4+ T cells expressing the alpha-chain of the interleukin-2
receptor, CD25, were depleted causing autoimmune disease (Sakaguchi et al.,
1995). Regulatory T cells comprise 5-10% of peripheral CD4+ T cells and
suppress autoimmune diseases, graft rejection, and innate mucosal immunity
(Maloy and Powrie, 2001; Maloy et al., 2003). CD25 is not always consistently
expressed and can be down-regulated to CD4+CD25- upon activation; however,
these cells can potentially remain suppressor cells (Chen et al., 2005). Forkhead
transcription factor family (FoxP3) and cytotoxic T lymphocyte antigen 4 (CTLA4)
are both considered activation markers for T regs. The X chromosome encodes
FoxP3 and a mutation causes X-linked autoimmune disease (Brunkow et al.,
2001). FoxP3 is a unique marker that was identified when normally suppressing
CD4+CD25+ cells were not suppressive in scurfy mice upon mutation on the X
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chromosome causing autoimmune disease (Li et al., 2008). Nearly all current
reports identify Tregs by their expression of FoxP3.
Tregs are immunosuppressive via two mechanisms, either by a cellcontact-dependent manner or by release of cytokines (Akenasy, 2008). The
release of cytokine IL-4, IL-10 and transforming growth factor (TGF)-β inhibit the
proliferation of T cells by suppression of IL-2 production (Thornton and Shevach,
1998).
T regs suppress immune activation by modulation of tryptophan
catabolism via CTLA-4 expression(Fallarino et al., 2003). CTLA-4 is an inhibitory
cell surface protein that out competes CD28 for binding to B7, a co-stimulatory
molecule, on antigen presenting cells. The enzyme used for catabolism of
tryptophan, indoleamine2,3-dioxygenase (IDO), is produced by antigen
presenting cells and trophoblasts to suppress T cell proliferation by the depletion
of tryptophan(Mellor, 2000). Dendritic cell IDO production is dependent upon the
activation marker CTLA-4 expression by Treg cells and INF-γ expression by
dendritic cells (Fallarino et al., 2003). IFN-γ production increases CTLA-4
expression on human decidual Treg cells which up-regulates IDO (Miwa et al.,
2005). Mice treated with increased concentrations of an IDO inhibitor showed a
dose dependent increase of fetal allograft rejection (Miwa et al., 2005).
Inflammation at the maternal-fetal interface resulted in failed pregnancies where
IDO expression was reduced in DCs and monocytes (Miwa et al., 2005).
Several studies have correlated increased number of activated Treg cells
in the periphery and decidua with successful pregnancies, while a reduced
number of Treg cells accompany failed pregnancies (Sasaki et al., 2004; Zhu,
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2005). Treg cells from normal pregnant mice were adoptively transferred to
abortion prone mice preventing fetal rejection (Zenclussen, 2006). Only Tregs
previously exposed to paternal alloantigens were found to have regulatory
activity that is needed to prevent miscarriage (Zenclussen, 2006). These Treg
populations can cross the placenta from the maternal to fetal side to reside in
lymph nodes with the ability to suppress auto-reactivity to the fetus (Mold et al.,
2008). This response has been shown to be induced in utero and assist in
regulating infant immune responses after birth (Mold et al., 2008).
Feline lentiviral infection and T regulatory cells
Feline T reg cells are also characterized by FoxP3 expression. Typically,
CD4+CD25+ T cell populations express FoxP3; however, in the cat, small
populations of CD4+CD25-, CD8+, and CD21+ lymphocytes also express FoxP3.
The population of feline Treg cells comprises 5-10% of the circulating CD4+
lymphocytes and 20-30% of lymph node CD4+ cells. This Treg population has
an IL-2-deficient anergic phenotype that is responsive to LPS and capable of
suppressing Con A-stimulated CD4+CD25- cells (Joshi et al., 2004).
CD4+CD25+ regulatory T cells are infected and activated during acute FIV
infection (Mexas et al., 2008). Higher viral mRNA levels were found in
CD4+CD25+ cells than CD4+CD25- suggesting increased viral replication or
infectivity early after infection. These cells remain activated throughout the
course of infection (Mexas et al., 2008). CD4+CD25+ T regulatory cells in acute
FIV infection up-regulated FoxP3 and TGF-β; furthermore, increased levels of
FoxP3 mRNA production were detected by intracellular protein expression
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(Mexas et al., 2008). It is still uncertain if natural regulatory T cells play a major
role in lentiviral pathogenesis of the virus or if the induced Tregs from naïve
CD4+ T cells have a larger contribution.
Th17 cells and pregnancy
Th17 cells differentiate from CD4+ T cells activated through antigenic
stimulation by IFN-γ or IL-4. These cells are responsible for secreting the
cytokine IL-17 and express transcription factor RORγ. Upon activation, Th17
cells have pro-inflammatory properties that induce the expression of several
cytokines and chemokines, including IL-6, IL-8, IL-21, IL-22, IL-17, TNFα, CXCL1
and CXCL10. IL-17 is important for recruitment of cell types responsible for the
elimination of gram-negative and fungal infections and can dictate the
recruitment of CD4+ Th1 cell response to control the infection (Bettelli, Korn, and
Kuchroo, 2007).
IL-17 has also been detected in murine studies with known autoimmune
diseases such as multiple sclerosis, rheumatoid arthritis, and psoriasis (Bettelli,
Korn, and Kuchroo, 2007). Mice deficient in the IL-23 cytokine, also responsible
for the proliferation of Th17 cells, had decreased production of IL-17 and
developed resistance to autoimmune diseases. Levels of IFN-γ did not differ
between deficient and non-deficient mice; however, with the decreased levels of
IL-17, recruitment of CD4+ T cells for a Th1 response may be affected.
Regulation of the T cell response results in an inverse relationship between T
regulatory cells exhibiting anti-inflammatory properties and Th17 cells exhibiting
pro-inflammatory properties (Bettelli, Korn, and Kuchroo, 2007).
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Transforming growth factor–β (TGF-β) is responsible for the induction of
FoxP3 transcription factor expressed in T regulatory cells. With the unveiling of
Th17 cells, a role for TGF-β in the differentiation of Th17 cells was also identified.
The immune system has an intricate cytokine system in place for the regulation
of expression of these two cell types. TGF-β causes the proliferation of both
Treg and Th17 cells from a common progenitor. T regulatory cells and Th17
cells have an inverse relationship controlled by the cytokine IL-6. During
inflammation, IL-6 production inhibits the induction of FoxP3 and, thus, the
generation of T regulatory cells. In the presence of both IL-6 and TGF-β, Th17
cells proliferate. Thus, IL-6 plays a prominent role in regulating a pro- or antiinflammatory immune response, a role that may be critical in placental
immunology and reproductive outcome. Our recent data showed a significant
increase in the level of IL-6 in early FIV-infected placental tissues, suggesting an
inflammatory microenvironment that may cause pregnancy failure (Scott et al.,
2011).
Several studies have demonstrated an increase in both Th17 cells and IL17 in the peripheral blood and in the decidual tissues of unexplained recurrent
spontaneous abortion (URSA) patients as compared to non-pregnant women (Liu
et al., 2011; Toldi et al., 2011) (Liu et al., 2010; Toldi et al., 2011). These data
indicate a role for Th17 in local pregnancy maintenance that occurs in parallel
with the systemic response (Liu et al., 2011).
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Significance and Purpose
The FIV-infected cat is a well-accepted small animal model for HIV
pathogenesis. We are using the FIV-infected cat to study immunopathology
occurring in the placenta as a consequence of viral infection that may result in
vertical transfer of the virus and/or reproductive failure. The first part of this
project examines the consequences of early FIV infection that occur in the
peripheral circulation of the queen. The significance of this research is that it may
provide insight into maternal serological, immunological, and virological
correlates that predispose vertical transfer and/or predict reproductive outcome.
Thus, we hypothesized that detectable serological, immunological, and
virological consequences accompany early maternal FIV infection, possibly
identifying maternal correlates of infection that are predictive of pregnancy
outcome. The objectives of part 1 were to: 1) quantify CD4+ and CD8+ T cell
population dynamics in blood samples collected from FIV infected and control
cats; 2) determine serological reactivity to viral proteins in longitudinal serum
samples; 3) quantify viremia in longitudinal blood samples; and 4) evaluate FIV
status, clinical consequences, and pregnancy outcome in queens.
The immunology of the placental environment must be precisely controlled
for pregnancy to be successful. Among the many leukocyte populations that are
involved in the placental immune response, two cell populations are emerging as
particularly relevant, Tregs and Th17 cells.Tregs suppress inflammation by
inhibiting activation of immune cells. Tregs areimportant in the maintenance of
pregnancy by allowing maternal tolerance of the semi-allogeneic fetus. FIV
replicates preferentially in and activates this cell population, potentially
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suppressing antiviral immunity and allowing chronic FIV infection to be
established. Tregs are present in the feline placenta and likely play an
immunosuppressive role.Th17 cells are a newly-recognized population of
inflammatory T cells whose role in reproductive failure and placental infection in
the human has recently come to light. There are no current reports of the
involvement of these cells in feline gestation. Altered function of both cell
populations resulting from FIV infection may produce placental
immunopathology, predisposing MTCT and/or reproductive failure. The second
part of this study focuses mainly on Treg dynamics in the feline placenta. We
hypothesized that FIV infection significantly impacts Treg dynamics and
activation in early and late-term placental tissues from viable and non-viable
pregnancies, predisposing MTCT and/or reproductive failure.
The following objective were addressed in part 2 of this study: 1) determine the
placental Treg population density in FIV-infected versus control cats; 2) evaluate
placental Treg activation in the study populations at early and late pregnancy by
measuring the expression of Treg products and cell surface markers; 3) quantify
virus load in these cells.
Likewise, we recently recognized the potential role for Th17 cells in
pregnancy and hypothesized that FIV infection impacts Th17 dynamics in the
same tissues. A preliminary objective was to determine whether these cells exist
in feline placentas and to quantify expression of the definitive Th17 marker,
RORγ.
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CHAPTER II
MATERNAL HEMATOLOGICAL AND VIROLOGICAL CHARACTERISTICS
DURING EARLY FELINE IMMUNODEFICIENCY VIRUS (FIV)
INFECTION OF CATS AS PREDICTORS OF FETAL
INFECTION AND REPRODUCTIVE OUTCOME
AT EARLY GESTATION
Boudreaux, C. E., N. N. Lockett, et al. (2009). Maternal hematological and
virological characteristics during early feline immunodeficiency virus (FIV)
infection of cats as predictors of fetal infection and reproductive outcome at early
gestation. Veterinary Immunology and Immunopathology 131(3-4): 290-297.
Abstract
The FIV-infected cat is a small animal model for HIV mother-to-child
transmission (MTCT) because the two lentiviruses are biologically related and
produce similar clinical syndromes. Both viruses are vertically transmissible and
may negatively impact reproductive outcome. Maternal hematological and
virological parameters are predictors of MTCT in HIV-infected women. Our
purpose was to determine whether similar maternal characteristics during early
pregnancy in FIV-infected cats influence pregnancy outcome. We inoculated ten
cats with FIV-B-2542; 10 cats were uninoculated.We quantified longitudinal
CD4:CD8 T cell ratios, proviral load, and plasma viremia, monitored longitudinal
serostatus, and documented clinical and reproductive outcome during early
pregnancy. Inoculated queens were seropositive and provirus positive by week 4
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post infection (p.i.). CD4:CD8 ratios were depressed in the infected group by
month 3.5 p.i. Proviral load was variable in the animals throughout the course of
infection; plasma viremia was below the level of detection in all animals.
Reduced litter sizes and increased fetal demise occurred in infected queens.
Viral RNA, but not proviral DNA, was detected in representative placentas (14 of
14; 100%) and fetuses (12 of 14; 86%) collected from infected queens.
However, maternal virological and hematological characteristics did not correlate
either positively or negatively with reproductive outcome.
Introduction
Globally, more than 420,000 children were newly infected with HIV in
2007, representing 16% of new HIV infections (UNAIDS, 2008). MTCT accounts
for more than 90% of pediatric infections (CDC, 2008). In addition, HIV infection
of pregnant women often results in poor outcome, including low-birth-weight
babies, preterm delivery, and enhanced incidence of spontaneous abortions
(D'Ubaldo et al., 1998; Kumar et al., 1995; Langston et al., 1995).
Maternal virological and hematological factors including plasma viremia
and CD4+ T cell counts influence HIV vertical transfer. MTCT typically
accompanies a decrease in the maternal CD4+ T cell population, resulting from
virus-mediated destruction of these cells (Deeks et al., 2004; McCune, 2001;
Yates et al., 2007), and high maternal plasma virus load (O'Donovan et al.,
2000).
The FIV-infected cat provides an excellent small animal model of HIV
MTCT because the viruses share many common genetic and biological features
32

and produce very similar clinical syndromes in their respective hosts (Willett et
al., 1997). FIV is readily transmitted from mother-to-child under experimental
conditions, resulting in pregnancy outcomes similar to those of HIV-infected
pregnant women.
A high rate of vertical transmission of FIV occurs late in gestation in
experimentally-infected cats with frequent reproductive failure (Allison and
Hoover, 2003a; O'Neil et al., 1996; Rogers and Hoover, 1998, 2002; Weaver et
al., 2005). We hypothesized that maternal virological and hematological
characteristics occurring during early pregnancy in the FIV-infected cat may be
predictive of pregnancy outcome. Our objectives were to: 1) quantify T cell
population dynamics occurring in the peripheral circulation of queens during early
FIV infection; 2) confirm and quantify FIV infection in longitudinal blood samples;
and 3) determine virus-induced reproductive outcome during early pregnancy.
We report reduced fecundity and increased fetal loss during early gestation in the
infected group. Viral RNA, but not provirus, was detected in placentas and
fetuses. The CD4:CD8 T cell ratio declined significantly in the infected group
within 3.5 months p.i. However, individual CD4:CD8 T cells ratios neither
positively nor negatively correlated with pregnancy outcome. Plasma viremia
was below detectable limits at all time points in all cats, but cats were provirus
positive and seropositive within four weeks p.i. and remained positive throughout
the duration of the experiment. Maternal hematological and virological correlates
of reproductive outcome were not clearly identified in this study.
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Materials and Methods
Animals and virus
Cats were female, reproductively mature, specific pathogen-free (SPF)
animals (Felis domesticus), obtained from a commercial cattery. Physical
evaluation of cats, including respiration, pulse rate, weight, and body condition,
was done two weeks prior to inoculation by trained veterinary staff. Ten cats
were inoculated intravenously with 1 cc of a feline plasma pool containing
approximately 1 x 104 copies per ml of FIV-B-2542 (Weaver et al., 2005); ten cats
were uninoculated controls. All animals were evaluated by caretakers on a daily
basis, and veterinary care was administered appropriately. Whole blood (15 ml)
was collected into Vacutainer7 tubes at biweekly to monthly intervals until
delivery for the collection of serum, plasma, and peripheral blood leukocytes
(PBLs). Following confirmation of infection by PCR and serology, described
below, queens were allowed to breed naturally with SPF males. The time of FIV
inoculation until delivery ranged from approximately 9.5 months to 13.5 months
(mean 11.14 months). Fetuses were delivered by cesarean section immediately
after pregnancies were confirmed by ultrasonography, at week 3-4 gestation.
Infected queens were euthanized following delivery using Beuthanasia at 1 cc
per 10 lb body weight. Control cats were spayed and released for adoption after
recovery. Fetuses, placentas, and amniotic fluids were collected from all
animals. Tissues were snap frozen in liquid nitrogen or fixed in formalin. Tissues
and amniotic fluids were frozen at -80C. Animal protocols were approved by the
Institutional Animal Care and Use Committee of Mississippi State University.
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Flow cytometric analysis of CD4+ and CD8+ T cell populations
Mouse anti-feline monoclonal antibodies to CD4 and CD8 conjugated with
phycoerythin (PE) and fluorescein isothiocyanate (FITC) (Southern Biotech,
Birmingham, AL), respectively, were diluted 1:20 in PBS. Whole blood was
sampled at 250 µl, and red cells were lysed with ACK lysing buffer (Quality
Biological, Inc., Gaithersburg, MD). All samples were washed with PBS and
centrifuged at 400 x g for 5 min using a Beckman TJ-6 centrifuge. Samples were
double stained with 40 µl of each diluted antibody and incubated 15 min at room
temperature in the dark. Flow cytometry was performed using FACSCalibur (BD
Biosciences, San Jose, CA); 10,000 events were collected.
Whole virus purification
Supernatant and cell lysate collected from FIV-infected T cell cultures
(MCH 5-4, kindly provided by Dr. John Elder) were centrifuged at 11,750 x g in a
GSA centrifuge at 4oC for 20 min to remove cellular debris. The clarified
supernatant was centrifuged at 23,000 x g for 90 min at 4 oC using an SW27 rotor
and a Beckman L8-80M Ultracentrifuge. The supernatant was discarded, and
the tubes were inverted and allowed to drain. Pellets containing virus were
resuspended in 200 µl of PBS and stored at -80oC. Real time reverse
transcriptase (RT)-PCR, described below, was used to confirm FIV RNA in these
preparations.
SDS-PAGE and Western blot
Viral proteins from the purified virus preparations were resolved under
reducing conditions on 12% SDS-polyacrylamide gels. Electrophoresis was
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done using a Mini Protein II system (Bio-Rad Laboratories, Hercules, CA),
according to standard procedure (Laemmli, 1970).
Proteins were trans-blotted onto nitrocellulose membranes (Micron
Separations Inc., Westborough, MA) using the Trans Blot SD Semi-Dry Transfer
cell (Bio-Rad) and Towbin buffer containing methanol (25mM Tris, 192mM
glycine, 20% methanol, pH 8.3). The nitrocellulose was cut into vertical strips for
use in Western blots.
Longitudinal serum samples (diluted 1:50) were evaluated by Western blot
according to established protocol (Whetstone, 1991). The secondary antibody
(diluted 1:1000) was goat anti-cat IgG peroxidase (MP Biomedicals, Solon, OH).
Blots were developed using a solution of 0.02 g 4-chloronapthol dissolved in 5 ml
of methanol, 25 ml 0.05 M Tris (pH 6.8), and 12 l hydrogen peroxide. Positive
and negative control sera, obtained from FIV-B-2542 inoculated and control cats
from a previous study (Weaver et al., 2005), were included in all Western blot
assays.
ELISA to detect FIV-specific antibody in serum
Longitudinal sera from the inoculated queens were evaluated for
seroconversion using the SNAP FIV/FeLV Combo Test Kit (IDEXX Laboratories,
Westbrook, ME), according to kit instructions. Sera collected at week 2 p.i and
thereafter were evaluated until seroconversion was detected.
ELISA to detect FIV p24 antigen in plasma
Plasma samples collected at three different time points p.i. were evaluated
for FIV p24 antigen using the Petcheck Feline Immunodeficiency Virus Antigen
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Test Kit (IDEXX Laboratories), according to kit instructions. Absorbance values at
650 nm (A650) for plasma samples and positive and negative controls (supplied in
kit) were measured using a plate reader. The cutoff value was calculated based
on mean values for negative controls. Samples with A650 values below the cutoff
value were considered negative.
Purification of DNA and RNA from feline plasma, PBLs, and tissues
TRIzol Reagent (Invitrogen, Carlsbad, CA) was used to fractionate RNA
and DNA from PBLs and sections of placental and fetal tissues. RNA was
purified from the aqueous phase as described (Scott et al., 2008). DNA was
further purified from the organic phase using the DNEasy Kit (Qiagen, Valencia,
CA). RNA was isolated from plasma using the QIAampViral RNA Mini Kit
(Qiagen). DNA and RNA concentrations were determined using a NanoDrop
1000 (Thermo Scientific, Waltham, MA) and frozen at -80oC. Viral RNA to be
used as standard was isolated from purified, whole virus, using the QIAamp Viral
RNA Mini Kit (Qiagen), treated with RNase-free DNAse, and quantified to
estimate copy number.
Detection of provirus in PBLs and placental and fetal tissue using PCR
FIV provirus was amplified from PBLs and feline tissues using standard,
nested PCR targeting a 293 bp region of the FIV gag gene (Allison and Hoover,
2003a, b). DNA obtained from FIV-B-2542 infected MCH 5-4 cells was used as a
positive control in PCR analyses. Reaction conditions were reported (Weaver et
al., 2005). The limit of detection was previously determined to be 1 to 10 copies
of target (Allison and Hoover, 2003a, b).
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Quantification of FIV provirus by limiting dilution PCR
A two-fold dilution series of DNA isolated from PBLs at three time points
p.i. was done to determine the end point dilution for detection of FIV provirus,
using PCR to detect the 293 bp gag proviral fragment. It was assumed that the
highest positive dilution of DNA contained at least one copy of provirus. Virus
load was estimated as copies per microgram of DNA.
Detection of FIV RNA in placentas, fetuses, and maternal plasma using
TaqMan real time RT-PCR
Real time TaqMan Primers and probes targeting the FIV gag gene and βactin were obtained commercially (MWG-BIOTECH, Inc., High Point, NC).
Sequences (Scott et al., 2008; Weaver et al., 2005) and 5’ and 3’ probe labels
(Scott et al., 2008) were previously reported. The real-time RT-PCR, targeting
FIV gag in placental, fetal, and plasma RNA, was done using an iCycler (BioRad) according to established parameters, and normalized Ct values were
determined (Scott et al., 2008). To determine the limit of detection, five-fold
dilutions of the RNA standard in DEPC-treated water (ranging from 1:5 to 1:1.95
x 106) were subjected to the real time RT-PCR protocol to achieve a standard
curve. The limit of detection was 2 x 104 copies/µl RNA.
Statistical analyses
Statistical evaluation of T cell populations was done using single-factor
ANOVA (Microsoft Excel-XP, Redmond, WA).
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Results and Discussion
Routine physical examination of control queens began at their arrival and
continued throughout the breeding period, which ranged from 5 months to 9.5
months (mean 7 months) after experimentation began. No noteworthy
abnormalities were revealed. Several abnormalities were noted among the FIVinfected group. Within approximately 6 weeks p.i., cat 6850 developed sudden
dehydration and fever which was unresponsive to antibiotic therapy. The cat was
euthanized at month 2 p.i. Cat 0326 developed conjunctivitis at month 3 p.i.
which responded well to antibiotic treatment. Three cats, 6062, 5587, and 3779
developed reproductive problems, discussed below.
Maternal hematological and virological characteristics are known to
influence maternal-fetal transmission of HIV. High levels of plasma viremia and
depressed CD4+ T cells positively correlate with fetal infection (O'Donovan et al.,
2000). We evaluated these predictors of early in utero transmission during the
first year of FIV infection in the cat model of MTCT.
For both control and infected groups, the mean percentages of CD4+ and
CD8+ T cells were determined at each time point sampled, and CD4:CD8 T cell
ratios were calculated. Longitudinal CD4:CD8 ratios for individual infected cats
are shown in Figure 2.1. The CD4:CD8 ratio for the control group was calculated
from the collective CD4+ and CD8+ T cell percentages of all control cats
measured. With the exception of cat 5111, whose CD4:CD8 ratio increased, FIV
infection caused a decreased T cell ratio in all cats. However, T cell dynamics
were not predictive of pregnancy outcome. The mean CD4:CD8 ratio was
significantly depressed in the infected group by month 3.5 p.i. (P=0.03), and it
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remained depressed at later sampling intervals. The decreased T cell ratio was
a result of depletion of the CD4+ T cell population in the infected group by month
3.5 p.i., while no significant changes were observed in the CD8+ T cells in the
infected group.

Figure 2.1

CD4:CD8 T cell ratios in longitudinal blood samples from FIVinfected cats.

The mean CD4:CD8 ratio for control cats, determined by compiling data from all
sample periods, is included for comparison (dashed line at 2.75 flanked by the
standard error of the mean, shaded in grey). Individual cat numbers are shown
in the legend at right. CD4+ and CD8+ T cells were quantified from whole blood
samples collected at regular times points p.i. The data are plotted beginning at 1
month p.i. and representative time points are shown through termination.
Although the T cell ratios fluctuated in individual animals over time, by delivery
and/or euthanasia at 9 to 12 months p.i., a decline in the CD4:CD8 T cell ratio
had occurred in all animals except cat 5111. CD4:CD8 ratios were significantly
different from the control by 3.5 months p.i. and at subsequent time points (P <
0.05).
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The mean CD4:CD8 T cell ratio determined for control cats in this study
was 2.7, falling within the normal range for cats (Dean et al., 1991; Novotney et
al., 1990). In a previous study, the CD4:CD8 T cell ratio in peripheral blood
dropped below 1.0 by twenty weeks of FIV infection and remained low
throughout the course of infection (Song et al., 1992). The depletion in the CD4+
T cell population was explained in part by the virus’s preferential infection of
activated CD4+ T cells, which most abundantly express CD134.
By week 4 p.i. all animals were weakly seropositive for FIV p24-specific
antibody, as determined by ELISA (Table 1). Nearly all cats remained
seropositive with increasing intensity of seroreactivity at subsequent time points
until termination/delivery (Figure 2.2). FIV provirus was detected in PBLs of all
infected animals at week 4 p.i. Animals remained provirus positive throughout the
duration of the study (Figure 2.2).
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Table 2.1

Maternal Hematology, Virology, and Pregnancy Outcome in Control
and Infected Queens

Cat
FIV
Plasma
number Serostatus* Viremia**

CD4:CD8 Viable Non- Reproductive
Ratio
Fetuses viable complications
(Terminal)
Fetuses
3550
nt
2.19
4
0
6108
nt
2.68
4
0
7824
nt
1.91
4
0
8291
nt
1.44
4
0
8059
nt
3.90
6
0
2779
nt
2.29
7
1
5373
nt
3.30
7
0
9276
nt
1.82
5
1
4102
nt
3.25
0
0
Unknown
uterine
abnormality
9307
nt
2.70
0
0
Failed to
conceive
Total
41
2
4.7% nonFetuses
viability
0326
+
2.09
1
0
8035
+
1.43
1
3
5111
+
2.57
2
1
0866
+
0.95
5
1
1893
+
1.39
5
1
6062
+
0.37
3
0
Right horn
pyometra
1126
+
0.43
4
0
5587
+
0.84
0
0
Pyometra
3779
+
1.18
0
0
Ovarian cysts
6850
+
N/A
0
0
Euthanized
before mating
Total
21
6
22.2% nonFetuses
viability
* Sera from all inoculated queens were tested by ELISA and Western blot;all
queens were positive by week 4 p.i.
**Plasma was tested by real time RT-PCR for viral RNA and by FIV p24 ELISA
for viral antigen.
nt = Not tested
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Figure 2.2

Detection of FIV provirus and FIV p24-specific antibodies in
longitudinal blood samples from FIV infected cats.

Left panels: FIV provirus was detected by standard PCR targeting a 293 bp
region of the gag gene. PCR products were resolved on 1% agarose gels. By
week 4 week p.i., the virus was detected in all infected animals. (+) shows the
PCR product amplified from DNA purified from cultured MCH 5-4 cells infected
with FIV-B-2542. Right Panels: Western blot analysis of longitudinal serum
samples (diluted 1:50) was performed following resolution of purified FIV proteins
on 12% SDS-PAGE gels and transfer to nitrocellose membranes. Positive and
negative controls (not shown) were sera obtained from FIV infected and
uninfected cats from a previous study. FIV p24 is the major immunodominant
viral protein, and seroreactivity was most consistent toward this protein.
Seroconversion was detected by week 4 p.i. and persisted until termination.
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Figure 2.3

Determination of FIV proviral copy number in longitudinal blood
samples and relative expression of viral RNA in placentas and
fetuses from FIV infected cats.
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2.3 (continued)
(A) Proviral copy number was determined using limiting dilution PCR targeting a
293 bp region of the FIV gag gene. Proviral load is reported as copies/ g DNA at
1 and 3 months p.i. and terminal time points. (B) Placental and (C) fetal
expression of FIV RNA was determined using TaqMan real time RT-PCR
targeting the FIV gag gene. Mean Ct values were determined from duplicate
samples. Ct values are inversely related to viral RNA load. Placentas or fetuses
from two uninoculated cats (6108 and 9276) were included as negative controls.
Mean positive control (striped bar) represents mean Ct values from 10 placental
samples from 6 FIV positive cats from a previous study.
Proviral loads, estimated as copy number per microgram of DNA, were
determined at months 1 and 3 p.i. and at delivery and/or euthanasia ( Figure
2.3A). By 1 month p.i., proviral loads varied among infected queens, ranging from
a low of 80 copies/µg DNA to greater than 3900 copies/µg DNA.
Interestingly, the proviral load of cat 6850, euthanized due to unresolvable
infection at month 2 p.i, was lowest of any cat at 1 month p.i. but increased more
than any other animal, a 41-fold increase by month 2 p.i (Figure 2.3A). This
increase in proviral load represented a 7-fold greater increase than in the cat
producing the next highest increase in provirus.
Proviral copy number in peripheral blood was neither positively nor
negatively correlated with pregnancy outcome. Queen 1893 produced the
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largest litter size, 5 viable fetuses and 1 non-viable fetus (Table 2.1), yet this
animal had the highest proviral load (> 2200 copies/µg DNA) of any
reproductively-successful animal (Figure 2.3A). On the other hand, queen 8035
produced the greatest amount of fetal damage (3 non-viable fetuses; 1 viable
fetus) (Table 2.1), but this animal had among the lowest terminal proviral loads
(Figure 2.3A).
Two animals who failed to conceive, cats 5587 and 3779, had among the
highest proviral loads (> 1000 copies/µg DNA) at the time of euthanasia (Figure
2.3A). While it is tempting to speculate that FIV infection caused the infertility of
these two cats, reproductive tissues from these two cats were not evaluated for
viral infection. Moreover, two control cats also failed to conceive after repeated
attempts at breeding. Consequently, the role that FIV infection may have played
in their reproductive pathologies is unclear.
The variability in proviral load that we observed is not uncommon in FIV
infection. Fluctuation in proviral loads during the course of infection due to a
decrease in infected CD4+ T cells was reported by others who determined that
CD4+ T cell depletion occurred as a result of targeting by cytolytic T lymphocytes
and apoptosis (Ohkura et al., 1997).
Using real time TaqMan RT-PCR targeting FIV gag RNA, fourteen
representative placentas and their corresponding fetuses were evaluated for viral
infection (Figure 2.3B and C). With the exception of queen 0326, who produced
only one offspring, two to three placentas per queen were evaluated (Figure
2.3B). Fourteen of fourteen placentas (100%) and twelve of fourteen fetuses
(86%) were positive. A comparison of mean Ct values provided a means to
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determine relative gene expression from each sample. Negative control tissues
yielded no fluorescent signal (Ct = 0); positive control tissue yielded a mean Ct
value of 27. Twelve of fourteen placentas were strongly positive (Ct < 30), while
two placentas (5111 B, 1126 A) gave a moderate reaction (Ct 31.4 and 30.1,
respectively). On the other hand, only three fetal specimens were strongly
positive (8035 C, 0866 A, and 0866 B) (Figure 2.3C). The remaining samples
were either moderately to weakly positive (Ct >30) or negative (8035 A and B). It
was interesting to note that two of three placentas from cat 8035 (A and B) were
negative, while the third placenta (8035 C) was strongly positive. Samples B and
C from this animal were placentas corresponding to arrested fetuses, while
sample A came from a viable fetus. Also, fetus 0866 A was viable while 0866 B
was a resorption. Both of these fetal samples were strong positives. While copy
number was not quantified in these samples, these data suggest that the virus
load in placental or fetal tissue did not determine pregnancy outcome.
Proviral DNA was not detected in placental or fetal tissues using standard,
nested PCR analysis. These findings indicate that our calculated real time RTPCR detection limit (2 x 104 copies/µl) is an underestimation of assay sensitivity,
probably due to co-purification of cellular RNA in our viral RNA standard, which
confounds calculation of viral copy number. Others (Rogers and Hoover, 1998)
were unable to detect fetal infection prior to 5 weeks of gestation but detected
infection in 96% of placentas at early, intermediate, and late stages of gestation,
using standard, nested PCR. MTCT occurring in HIV-infected women is most
frequent during late stages of pregnancy and at delivery (Brossard et al., 1995;
Chouquet et al., 1999).
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FIV p24 antigen was not detected in any of the plasma samples collected
from infected cats at any time point p.i. Likewise, viral RNA was not amplified
from plasma samples from infected cats at any time period. Spiking plasma with
standard viral RNA resulted in amplication, proving that reaction conditions were
appropriate. Thus, plasma viremia was below the level of detection in all animals.
Maternal plasma viral RNA loads were measured previously in FIV-B-2542infected queens at 3, 5, 7, and 9 weeks pregnancy. Plasma viral RNA loads
below the detection threshold (1000 copies/ml) occurred in nearly half the
queens, regardless of pregnancy stage, and only one animal had a plasma viral
RNA load above the threshold value (Rogers and Hoover, 1998).
Pregnancy outcome in individual control and infected queens is reported
(Table 1). Eight control cats produced 41 viable and 2 non-viable fetuses (4.7%
non-viability), an average of 5.4 offspring/litter. Two control animals failed to
conceive. An undiagnosed uterine abnormality was noted upon ultrasonography
of one of these animals (4102). The other cat, 9307, showed no evidence of
reproductive pathology. Both of these animals were otherwise clinically normal.
Seven infected queens produced 21 viable and 6 non-viable fetuses (22.2% nonviability), an average of 3.9 offspring/litter. Infected cats 5587 and 3779 failed to
conceive after repeated matings, due to pyometra and ovarian cysts,
respectively. Cat 6062, who produced 3 viable fetuses in the left uterine horn,
had right horn pyometra at delivery. The difference in the number of viable
fetuses between the infected and control groups, nearly 50% fewer in infected
cats, was significant (P=0.02). Although three times higher in the infected group,
fetal non-viability failed to reach the traditional level of significance (P>0.05).
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High rates of fetal non-viability in full or near-full term FIV-infected cats were
reported elsewhere (O'Neil et al., 1995; Weaver et al., 2005), but rates of fetal
demise in FIV-infected cats at this early stage of pregnancy have not been
reported.
These same maternal hematological and virological characteristics were
not evaluated by us at late pregnancy, where high rates of fetal infection and
increased reproductive failure occurred (Weaver et al., 2005). However, other
investigators found that these maternal markers did not change significantly with
gestational age, although MTCT correspondingly increased (Rogers and Hoover,
1998).
In summary, maternal correlates of HIV vertical transmission, including
peripheral blood provirus load, plasma viremia, and depressed CD4+ T cell
populations, neither positively nor negatively correlated with fetal infection or
pregnancy outcome in the FIV-infected cat model at 3-4 weeks gestation. Our
data, coupled with those reported previously (Rogers and Hoover, 1998), indicate
that the experimentally-infected cat may not adequately model these particular
maternal correlates of HIV MTCT. However, it is clear that early FIV infection
reduced fecundity, compromised reproductive outcome, and resulted in a high
rate of MTCT during early weeks of pregnancy. The inability to correlate fetal
infection with reproductive outcome suggests an indirect mechanism of fetal
damage, such as virus-induced placental pathology or pathology of other
reproductive tissues. We previously reported preliminary evidence for a role for
placental inflammation in compromised pregnancy in the FIV-infected cat (Scott
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et al., 2008; Weaver et al., 2005). The effect of FIV infection on placental immune
parameters at early and late pregnancy is currently ongoing.
Acknowledgements
We would like to thank Dr. Sang-Ryul Lee for assistance with flow
cytometry. We express gratitude to Dr. Kathleen Wilkinson and Jamie Allison for
veterinary assistance. This project was supported by the National Institutes of
Health project # 2R15AI048410-02A1.

50

References
Allison, R.W., Hoover, E.A., 2003a, Covert vertical transmission of feline
immunodeficiency virus. AIDS Res Hum Retroviruses 19, 421-434.
Allison, R.W., Hoover, E.A., 2003b, Feline immunodeficiency virus is
concentrated in milk early in lactation. AIDS Res Hum Retroviruses 19,
245-253.
Brossard, Y., Aubin, J.T., Mandelbrot, L., Bignozzi, C., Brand, D., Chaput, A.,
Roume, J., Mulliez, N., Mallet, F., Agut, H., et al., 1995, Frequency of early
in utero HIV-1 infection: a blind DNA polymerase chain reaction study on
100 fetal thymuses. Aids 9, 359-366.
CDC 2008.Cases of HIV Infection and AIDS in the United Stated and Dependent
Areas, 2006.
Chouquet, C., Richardson, S., Burgard, M., Blanche, S., Mayaux, M.J., Rouzioux,
C., Costagliola, D., 1999, Timing of human immunodeficiency virus type 1
(HIV-1) transmission from mother to child: bayesian estimation using a
mixture. Stat Med 18, 815-833.
Dean, G.A., Quackenbush, S.L., Ackley, C.D., Cooper, M.D., Hoover, E.A., 1991,
Flow cytometric analysis of T-lymphocyte subsets in cats. Vet Immunol
Immunopathol 28, 327-335.
Deeks, S.G., Kitchen, C.M., Liu, L., Guo, H., Gascon, R., Narvaez, A.B., Hunt, P.,
Martin, J.N., Kahn, J.O., Levy, J., McGrath, M.S., Hecht, F.M., 2004,
Immune activation set point during early HIV infection predicts subsequent
CD4+ T-cell changes independent of viral load. Blood 104, 942-947.
D'Ubaldo, C., Pezzotti, P., Rezza, G., Branca, M., Ippolito, G., 1998, Association
between HIV-1 infection and miscarriage: a retrospective study.
DIANAIDS Collaborative Study Group.Diagnosi Iniziale Anomalie
Neoplastiche AIDS.Aids 12, 1087-1093.
Kumar, R.M., Uduman, S.A., Khurranna, A.K., 1995, Impact of maternal HIV-1
infection on perinatal outcome. Int J Gynaecol Obstet 49, 137-143.
Laemmli, U.K., 1970, Cleavage of structural proteins during the assembly of the
head of bacteriophage T4. Nature 227, 680-685.
Langston, C., Lewis, D.E., Hammill, H.A., Popek, E.J., Kozinetz, C.A., Kline,
M.W., Hanson, I.C., Shearer, W.T., 1995, Excess intrauterine fetal demise
associated with maternal human immunodeficiency virus infection. J Infect
Dis 172, 1451-1460.
51

McCune, J.M., 2001, The dynamics of CD4+ T-cell depletion in HIV disease.
Nature 410, 974-979.
Novotney, C., English, R.V., Housman, J., Davidson, M.G., Nasisse, M.P., Jeng,
C.R., Davis, W.C., Tompkins, M.B., 1990, Lymphocyte population
changes in cats naturally infected with feline immunodeficiency virus. Aids
4, 1213-1218.
O'Donovan, D., Ariyoshi, K., Milligan, P., Ota, M., Yamuah, L., Sarge-Njie, R.,
Whittle, H., 2000, Maternal plasma viral RNA levels determine marked
differences in mother-to-child transmission rates of HIV-1 and HIV-2 in
The Gambia. MRC/Gambia Government/University College London
Medical School working group on mother-child transmission of HIV.Aids
14, 441-448.
Ohkura, T., Shin, Y.S., Wakamiya, N., Iwa, N., Kurimura, T., 1997, Detection of
proviruses and viral RNA in the early stages of feline immunodeficiency
virus infection in cats: a possible model of the early stage of HIV infection.
Exp Anim 46, 31-39.
O'Neil, L.L., Burkhard, M.J., Diehl, L.J., Hoover, E.A., 1995, Vertical transmission
of feline immunodeficiency virus. AIDS Res Hum Retroviruses 11, 171182.
O'Neil, L.L., Burkhard, M.J., Hoover, E.A., 1996, Frequent perinatal transmission
of feline immunodeficiency virus by chronically infected cats. J Virol 70,
2894-2901.
Rogers, A.B., Hoover, E.A., 1998, Maternal-fetal feline immunodeficiency virus
transmission: timing and tissue tropisms. J Infect Dis 178, 960-967.
Rogers, A.B., Hoover, E.A., 2002, Fetal feline immunodeficiency virus is
prevalent and occult. J Infect Dis 186, 895-904.
Scott, V.L., Burgess, S.C., Shack, L.A., Lockett, N.N., Coats, K.S., 2008,
Expression of CD134 and CXCR4 mRNA in term placentas from FIVinfected and control cats. Veterinary Immunology and Immunopathology,
Feline Retrovirus Research and Genomics Symposium 123, 90-96.
Song, W., Collisson, E.W., Billingsley, P.M., Brown, W.C., 1992, Induction of
feline immunodeficiency virus-specific cytolytic T-cell responses from
experimentally infected cats.J Virol 66, 5409-5417.
UNAIDS 2008. Key facts by region - 2008 Report on the global AIDS epidemic.
In Report on the global AIDS epidemic 2008.
52

Weaver, C.C., Burgess, S.C., Nelson, P.D., Wilkinson, M., Ryan, P.L., Nail, C.A.,
Kelly-Quagliana, K.A., May, M.L., Reeves, R.K., Boyle, C.R., Coats, K.S.,
2005, Placental immunopathology and pregnancy failure in the FIVinfected cat. Placenta 26, 138-147.
Whetstone, C.A., VanDerMaaten, M.J., and Miller, J.M., 1991, A western blot
assay for the detection of antibodies to bovine immunodeficiency-like virus
in experimentally infected cattle, sheep, and goats. Arch Virol 116, 119131.
Willett, B.J., Flynn, J.N., Hosie, M.J., 1997, FIV infection of the domestic cat: an
animal model for AIDS. Immunol Today 18, 182-189.
Yates, A., Stark, J., Klein, N., Antia, R., Callard, R., 2007, Understanding the
slow depletion of memory CD4+ T cells in HIV infection. PLoS Med 4,
e177.

53

CHAPTER III
TH17/TREG POPULATIONS AT EARLY AND LATE TERM GESTATION IN
FELINE IMMUNODEFICIENCY VIRUS (FIV) INFECTED AND
UNINFECTED PLACENTAL TISSUE
Abstract
The T cell immune response plays an important role in the maintenance of
pregnancy. Regulatory T cell (Treg) populations, an immunosuppressive
population of CD4+ T cells, are essential in maintaining the anti-inflammatory
placental microenvironment that protects the semi-allogeneic fetus from the
maternal immune response. Th17 cells are a pro-inflammatory CD4+ T cell
population involved in autoimmune disease and the protective response to
extracellular microbes. Low levels of Tregs, and conversely, abnormally high
levels of Th17 cells in the placenta are associated with reproductive failure in
humans. We previously found evidence of a pro-inflammatory placental
microenvironment in feline immunodeficiency virus (FIV)-infected cats at early
pregnancy and a high rate of reproductive failure in these animals. We
hypothesized that FIV infection in the pregnant cat causes altered placental Treg
and Th17 cell populations, possibly allowing lentivirus-induced placental
inflammation and frequent fetal demise. We quantified the expression of Treg
marker FoxP3 and Th17 marker RORγin placental samples from FIV-infected
and control queens at early and late term gestation by measuring fluorescence
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intensity by confocal microscopy. We detected significantly higher levels of
RORγ in FIV-infected placentas at early pregnancy, indicating that the viral
infection caused increased numbers of Th17 cells to be localized in the placenta
at this stage of pregnancy. These data shed additional light on the mechanism of
FIV-induced inflammation in the feline placenta.
Introduction
The phenomenon of immune tolerance to the fetal allograft is not fully
understood. Paternal antigens expressed by the embryo must be tolerated by
the maternal immune system for pregnancy to be successful. Maternal tolerance
is accomplished, in part, by the expression of cytokines and other
immunoregulatory molecules at the maternal-fetal interface which modulate
appropriate placental immunology (Kwak-Kim et al., 2010; Mellor, 2000). The
Th1/Th2 paradigm, which assumed that Th2 (anti-inflammatory) cytokines
dominate the maternal-fetal interface during most of pregnancy while Th1 (proinflammatory) cytokines are suppressed, has been recently succeeded by a
Th1/Th2/Th17 and regulatory T cell paradigm (Saito et al., 2010) which allows for
a cytokine milieu during various stages of pregnancy which does not fit the
traditional Th1/Th2 model.
Tregs are an immunosuppressive T cell population characterized
phenotypically by the surface expression of CD4 and CD25 (the alpha chain of
the IL-2 receptor) and intranuclear expression of the transcriptional activator
FoxP3. Tregs facilitate an anti-inflammatory response with the release of IL-10
and TGF-β which suppress expression of such inflammatory cytokines as IL-17.
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Their role in pregnancy maintenance was recently recognized. An increased
number of Tregs were reported in the circulation and decidua at normal
pregnancy, while a reduced number of Treg cells accompanied failed
pregnancies (Sasaki et al., 2004; Yang et al., 2008;Zhu, 2005).
Feline CD4+CD25+ Tregs were previously described (Joshi et al., 2004).
These cells express both intranuclear FoxP3 and surface TGF-β. Their function
parallels that of human and murine Tregs (Joshi et al., 2004). Furthermore, FIV
replicates preferentially in the cells during acute infection, producing high levels
of viral RNA which correspond to peak plasma viremia (Mexas et al., 2008).
Th17 cells are a pro-inflammatory population of T cells that differentiate
from CD4+ T progenitor cells in the presence of TGF-β and IL-6. Among other
pro-inflammatory cytokines and chemokines, these cells secrete the cytokine IL17 and express transcription factor RORγ. (Bettelli, Korn, and Kuchroo, 2007).
The role of these cells in human pregnancy is under investigation. Lower
population numbers of Th17 cells were associated with normal pregnancies while
increased numbers corresponded to spontaneously aborted fetuses (Liu et al.,
2011). Increased levels of IL-17 in the periphery caused decreased
immunosuppressive ability of Tregs, a finding which was speculated to lead to
increased spontaneous abortions (Wang et al., 2010). Collectively, the data
suggest an inverse relationship between Tregs and Th17 during gestation. Feline
Th17 cells have not yet been described.
We are using the FIV-infected cat to model lentivirus-induced placental
immunopathology. We reported that FIV infection results in significantly
increased reproductive failure which corresponds to an infection-induced, pro56

inflammatory placental microenvironment, particularly at early pregnancy. Our
previous report (Lockett et al., 2010) suggests that infection may reduce the
population of placental Tregs at early pregnancy, partially explaining the proinflammatory state of the tissue. In the present study we hypothesized that FIV
infection in the pregnant cat causes altered placental Treg and Th17 cell
population dynamics, possibly allowing placental inflammation as a result of
infection and frequent fetal demise. We quantified the expression of Treg marker
FoxP3 and Th17 marker RORγin placental samples from FIV-infected and
control queens at early and late term gestation by immunofluorescence confocal
microscopy. Th17 cells were significantly increased in infected placentas at
early, but not late pregnancy. A negative correlation in FoxP3 versus RORγ
expression was predicted because Tregs and Th17 cells are inversely related.
However, a significant negative correlation of Tregs and Th17 cells was evident
only in control animals late in pregnancy. A positive correlation of these cells
approached, but did not reach significance in FIV infected tissues at early
pregnancy. Collectively, the data provide the first evidence that a Treg/Th17
imbalance may occur in early pregnancy in the FIV-infected cat, supporting our
prior evidence of a virus-induced, pro-inflammatory placental microenvironment
at early pregnancy.
Materials and Methods
Animals and Virus
Cats were female, reproductively mature, specific pathogen-free (SPF)
animals (Felis domesticus), obtained from a commercial cattery. Ten cats were
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inoculated intravenously with 1 cc a feline plasma pool containing FIV-B-2542 at
approximately 1 x 104 copies per ml; ten cats were uninoculated controls. Whole
blood (15 ml) was collected into Vacutainer® tubes at biweekly to monthly
intervals until delivery of kittens. Serum, plasma, and peripheral blood
leukocytes (PBLs) were collected. Confirmation of infection was performed by
standard PCR and serology (Boudreaux et al., 2009; Weaver et al., 2005).
Queens were allowed to breed naturally with SPF males. Fetuses were
delivered by cesarean section immediately after pregnancies were confirmed by
ultrasonography at week 3-4 gestation (early term) or at 8 weeks gestation (late
term). The time of FIV inoculation to delivery ranged from approximately 9.5 to
13.5 months (mean 11.14 months) for the early-gestation study and 4.7 to 14.1
months (mean 9.5 months) for the late-gestation study. Fetal and placental
tissues were collected from all animals, snap frozen in liquid nitrogen, and frozen
at -80˚C. Infected animals used were euthanized following delivery. Control cats
were spayed and released for adoption after recovery. Animal protocols were
approved by the Institutional Animal Care and Use Committee of Mississippi
State University. The placental tissues used in this study are shown in Table 1.
Detection of Virus in Tissue
Placental tissues were evaluated for FIV provirus using standard PCR or
for viral RNA targeting FIV gag using qPCR according to the published protocols
(Lockett et al., 2010; Weaver et al., 2005).
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Immunofluorescent staining
Snap frozen placental tissues were embedded in OCT (Tissue-Tek®,
Sakura Finetek, Torrance, CA.) and sectioned to a thickness of 4um using a
cryostat. Five random sections for each placenta collected from the
maternal/fetal interface were placed on poly-L-lysine coated slides and allowed to
dry. Tissues were fixed in acetone (100%) for 15 minutes at room temperature
and then treated with 0.01% Triton-X-100 to permeabilize the tissue. Sections
were blocked with feline IgG (0.1mg/ul) and 5% non-fat milk, and incubated at
40C for at least 1 hour. Sections were incubated with the primary antibodies
rabbit polyclonal antibody to RORγ (abcam; dilution 1:500), and rabbit polyclonal
antibody to FoxP3 (abcam; dilution 1:500) for 2h at 4oC. Secondary antibody,
goat anti-rabbit IgG (H+L) fluorescein conjugated (CHEMICON, Temecula, CA,
1:500), was applied and incubated 45 minutes to 1h at 4oC. Parallel sections
were treated with isotype-matched control antibodies (Dako North America Inc.,
Carpinteria CA.) conjugated with appropriate fluorochromes to assure that
reactivity was not a result of non-specific binding. Sections were mounted with
Vecta shield containing DAPI (Vector Laboratories, Inc.).
Confocal Microscopy
The fluorescence intensity was acquired using a Zeiss LSM 510 Confocal
Laser Scanning Microscope (Carl Zeiss Microimaging, Inc) with an Inverted Zeiss
Axiovert 200 M Light microscope and a plan apochromat 40 X/1.30 NA objective
lens. A DAPI/fluorescein filter set was used in single channel mode imaging.
Excitation wavelengths of 405nm and 488nm were used and Band Pass (BP)
Emission wavelengths of 420-480 nm (Blue) and Long Pass (LP) 505nm (Green)
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were acquired at 1024x1024 pixel format for imaging purposes. Fluorescence
intensity was collected from 10 randomly selected fields of view per section.
Background fluorescence was acquired for each sample using the secondary
antibody.
Statistical Analysis
Statistical analyses of mean fluorescence intensity for targeted cell
populations from (FoxP3 and RORγ) between FIV control and infected cats were
done using single-factor ANOVA. Spearman Rank Order
Correlation(http://www.wessa.net/rankcorr.wasp) was used to determine the
correlation between FoxP3 and RORγ. Differences were considered significant
at p ≤ 0.05.
Results
FIV infection status of placental tissues
FIV provirus or viral RNA was detected in all placental tissues tested
(Lockett et al., 2010; Weaver et al., 2005). Placental samples and infection
status are listed in Table 3.1.
Quantification of Treg and Th17 markers at early and late gestation
FoxP3 and RORγ expressing cells were detected at the maternal-fetal
interface of representative samples following labeling with primary polyclonal
antibody to the two proteins and FITC-conjugated secondary antibody (Fig 3.1).
Negative control reactions ( 3.1, top panel) showed minimal background
fluorescence, validating the specificity of the primary antibodies. The
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fluorescence intensity of FoxP3 and RORγ was visibly higher in the infected
group as compared to the controls ( 3.1, middle panel). The intranuclear
expression of FoxP3 and RORγ was evident when fluorescently-labeled cells
were stained with DAPI ( 3.1, bottom panel), identifying those cells as Tregs or
Th17 cells, respectively.
The cell populations were quantified by measuring the mean fluorescence
intensity of the respective cellular markers. There was no significant difference in
the Treg population between infected and control groups at either early (p=0.34)
or late (p=0.29) gestation (Fig 3.2A). At early gestation the fluorescence intensity
for RORγ was significantly higher in the infected than the control group
(p=0.003), suggesting a greater population of Th17 cells in this group. No
significant differences (p=0.21) in the Th17 population at late gestation were
evident (Fig 3.2B).
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Table 3.1

Placental samples included in confocal analysis.

Placenta Number Queen Placental Fetus* Placenta Number Queen Placental Fetus*
Early Pregnancy

FIV

FIV

Late Pregnancy

FIV

FIV

Status

Status

Status

Status

7824A

-

-

V

13671 AP

-

-

V

7824B

-

-

V

13671 DP

-

-

V

7824C

-

-

V

13668 AP

-

-

V

2779A

-

-

V

13668 BP

-

-

V

2779E

-

-

V

9746 AP

-

-

V

6108A

-

-

V

9746 DP

-

-

V

8291A

-

-

V

9801 AP

-

-

V

8291B

-

-

V

9801 BP

-

-

V

9784B

-

-

V

9674 AP

+

+

V

6062B

+

+

V

9809 A

+

+

V

6062C

+

+

V

13226 1P

+

+

NV

8035B

+

+

NV 13226 2P

+

+

NV

1893B

+

+

NV 9703 R1

+

+

NV

1893C

+

+

V

9813 R1

+

+

NV

1126A

+

+

V

9813 R2

+

+

NV

1126D

+

+

V

5111A

+

+

V

5111C

+

+

NV

0866B

+

+

V

*Viable (V), Nonviable (NV)
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FIV +

FIV -

Control
(2 Ab
only)

Control
(2 Ab
only)

FITC

FITC

DAPI/
FITC

DAPI/
FITC

ROR

Figure 3.1

ROR

FOXP3

FOXP3

Immunofluorescence labeling of RORγ and FoxP3 at the maternal
fetal interface of tissue from representative infected and control cats.

Negative controls included no primary antibody (top panels).RORγ and FoxP3
(green) were detected using polyclonal rabbit anti-FoxP3 or anti-RORγ antiserum
followed by goat anti-rabbit IgG (H + L) fluorescein conjugate (middle panels).
Cells were counterstained with DAPI (blue) (bottom panels). Cells were viewed
by confocal laser scanning microscopy using a 40x oil immersion objective.
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(A)

(B)
Figure 3.2

Quantification of Treg (A) and Th17 (B) cell populations at the
maternal fetal interface.

Mean fluorescence intensity of FoxP3 and RORγ, which label Treg and Th17
cells, respectively, were measured at early and late term gestation in both control
and infected cats. Values are bracketed by standard error of the mean.
Samples were evaluated as follows: infected (n=11) versus control (n=9) at early
gestation; and infected (n=7) versus control (n=8) at late gestation. P values <
0.05 were considered significant.
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Correlation of RORγ and FoxP3 at early and late gestation
RORγ and FoxP3 expression neither positively nor negatively correlated in
either FIV positive or control cats at early gestation ( 3.3A and B), although a
positive trend approached significance (p=0.069) in FIV positive cats at this
stage. At late gestation the RORγ:FoxP3 correlation was not significant in FIV
positive cats, but the negative correlation of RORγ:FoxP3 was significant
(p=0.05) in control animals at late pregnancy ( 3.4A and B), indicating a normal
reciprocal relationship in these cell populations at this stage of pregnancy.
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(A)

(B)

Figure 3.3

Correlation of RORγ to FoxP3 in infected (A) and control (B) cats at
early gestation.

Analysis was performed using Spearman Rank Order Correlation. P values
<0.05 were considered significant.
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(A)

(B)

Figure 3.4

Correlation of RORγ to FoxP3 in infected (A) and control (B) cats at
late gestation.

Analysis was performed using Spearman Rank Order Correlation. P values
<0.05 were considered significant.
Discussion
During normal human pregnancy, Treg populations expand in the blood
and deciduum as pregnancy progresses, while the Treg population decreases in
failed pregnancies (Sasaki et al., 2004). In HIV-positive women, the Treg
population in blood was unchanged between the first and second trimester (Kolte
et al., 2011). No data are available to evaluate the influence of HIV infection on
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placental Treg populations in women. We are evaluating placental Treg
populations in the FIV-infected cat model. Previously, we used qPCR to detect
expression of Treg markers in sections excised from whole placentas. Lower
levels of FoxP3 and CTLA4 expression occurred in placentas of FIV-infected cats
as compared to control cats at early pregnancy, indicating a possibly reduced
population of Tregs in infected animals at this stage (Lockett et al., 2010). In the
present study we used confocal microscopy to identify and quantify these cells
specifically in immuno-labeled tissues based on fluorescence intensity. We were
unable to detect significant differences in FoxP3 expression between FIV
infected and control cats at either early or late pregnancy.
Knowledge of the role of Th17 cells in pregnancy is newly emerging.
Significantly higher numbers of Th17 cells were detected in the decidua of
patients who spontaneously aborted as compared to patients with normal
pregnancies (Liu et al., 2011; Tomi, Nishimura, and Nakashima, 2011). IL-17 was
localized in both cytotrophoblasts and syncytiotrophoblasts of normal, early
pregnancy patients and those exhibiting unexplained recurrent spontaneous
abortions (URSA), although IL-17 was significantly high in URSA patients. Cells
other than lymphocytes also expressed IL-17 at the maternal-fetal interface of
URSA patients (Liu et al., 2011).
TGF-β normally drives the differentiation of both Tregs and Th17 cells
from progenitor CD4+ T cells. Generation of Th17 cells requires the additional
presence of IL-6 and IL-21 (Deenick, 2007). In an inflammatory environment,
Tregs can convert into Th17 cells (Xu et al., 2007; Zheng, Wang, and Horwitz,
2008). We found that FIV infection alters cytokine expression in the placenta.
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Among these cytokines, IL-6 was significantly increased in FIV-infected cats at
early pregnancy. A positive correlation between viral load and IL-6 at late
pregnancy was reported (Scott et al., 2011). Those data indicate a placental
microenvironment conducive to Th17 dominance in the FIV-infected cat model,
and in the present study, Th17 cells were significantly increased in placentas
from FIV-infected cats at early, but not late pregnancy. These data explain, in
part, the pro-inflammatory placental microenvironment that we previously
speculated (Scott et al., 2011).
Treg and Th17 cell populations are normally negatively correlated with
reciprocal developmental pathways for inflammation and immune regulation (Xu
et al., 2007; Zheng, Wang, and Horwitz, 2008). We detected a significant
negative correlation of FoxP3 and RORγ expression at late pregnancy in the
control group. A trend toward a negative correlation between the two populations
in control placentas at early pregnancy and in the FIV-infected group at late
pregnancy did not reach the level of significance. A trend toward a positive
correlation approached, but did not reach significance (p=0.069) in the FIV
positive, early pregnancy group.
These data lead us to speculate that Th17 cells may arise from and
contribute to the localized inflammatory microenvironment that occurs in the
placentas of FIV-infected queens at early pregnancy. An increased presence of
Th17 cells in the uterine cavity has previously been suggested due to the nonsterility of the cavity and the contribution of Th17 cells to the protective immune
response to extracellular microbes (Saito et al., 2010). The Th17-induced proinflammatory placental microenvironment resulting from HIV infection in women
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and in our FIV-infected cat model may pose a dilemma for the developing fetus
by causing an imbalance of regulatory and protective cytokines that results in the
enhanced pregnancy failure that occurs in these lentiviral infections.
In summary, our data indicate a significant increase in the Th17 cell
population in early-term placentas from infected feline queens. This result is
consistent with our previous reports of a pro-inflammatory placental
microenvironment at this stage of pregnancy in FIV-infected queens and an
enhanced rate of reproductive failure in this group of cats. Currently,
immunomodulator profiles from laser capture microdissected Treg and Th17 cells
and adjacent placental microenvironments are being evaluated in the FIVinfected cat model. These profiles may illuminate the functional effects of viral
infection on these immunologically-important placental cell populations.
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CHAPTER IV
EVIDENCE FOR PLACENTAL TREG IMMUNOMODULATORS IN THE FIV
INFECTED CAT MODEL
Abstract
Treg cells are important in the maintenance of pregnancy and are
preferentially infected and activated during acute FIV infection.TGF-β promotes
initial differentiation of both Tregs and Th17 cells from a common progenitor. IL6 promotes further progression to the Th17 phenotype and arrests further
differentiate of Tregs. Thus, Tregs and Th17 cells should be have an inverse
relationship controlled by IL-6. Disruption in expression of the cytokine
potentially perturbs the balance in the two cell populations. We previously found
evidence of a pro-inflammatory placental environment with decreased levels of
FoxP3 and increased levels of IL-6 in the placentas of FIV-infected cats at early
pregnancy with a high rate of reproductive failure. We hypothesized that FIV
infection in pregnant cats causes alteration in placental Treg populations and
increased inflammation, potentially allowing transplacental transmission of the
virus and frequent damage to the fetus. We showed the localization of Treg and
Th17 cells at the maternal-fetal interface and quantified the expression of Treg
modulators FoxP3, CD134, CXCR4, IL-10, and TGF-β in placental samples from
FIV-infected and control queens at early pregnancy by qPCR. We correlated the
expression of IL-6 and RORγ for the characterization of Th17 cells. We detected
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significantly higher levels of TGF-β in infected queens, indicating dysregulation in
both Treg and Th17 cell populations. In control cats the expression of IL-6 and
RORγ was positively correlated as predicted, but this relationship was disrupted
in infected animals.These data are consistent with our previous reports of a proinflammatory placental microenvironment at this stage of pregnancy in FIVinfected queens that may include perturbation of Th17 cell dynamics.
Introduction
Feline Tregs, characterized by detection of intracellular expression of
FoxP3, arepreferentially infected and activated during acute FIV infection
(Mexas, Fogle et al. 2008). The expression of both FoxP3 and TGF-β are upregulated in Tregs of infected animals (Mexas, Fogle et al. 2008). Tregs and
Th17 cells differentiate from a common T helper progenitor cell. TGF-β causes
the proliferation of both Treg and Th17 cells (Mangan, Harrington et al. 2006)(Li,
Wan et al. 2007). During inflammation, enhanced production of IL-6 inhibits the
induction of FoxP3, halting the generation of Tregs, and activates the expression
of RORγ, driving the proliferation of Th17 cells (Bettelli, Korn et al. 2007). Th17
cells further enhance the inflammatory response by releasing the cytokines IL17,
IL-6, TNFα, and IL-22. Thus, IL-6 levels dictate a pro- or anti-inflammatory
cellular response and an inverse relationship between Tregs and Th17 cells
(Bettelli, Korn et al. 2007). Disruption in cytokine expression potentially perturbs
the balance in the two cell populations.
Cytokines at the maternal-fetal interface play an essential role in the
maintenance of pregnancy. This site favors, but is not limited to, an anti75

inflammatory environment during early to mid-pregnancy (Mellor 2000).
Suppression of inflammatory cytokines is necessary in the early stages of
pregnancy because inflammation may cause pre-eclampsia, pre-term delivery,
and/or spontaneous abortion (Lim, Odukoya et al. 2000; Makhseed, Raghupathy
et al. 2000;Makhseed, Raghupathy et al. 2001). Late in pregnancy inflammation
is necessary to induce parturition (Guerin, Prins et al. 2009). A significant
decrease in the Treg population in the decidua during late pregnancy allows an
inflammatory response to precede parturition, an important factor in the expulsion
of the full term fetus (Guerin, Prins et al. 2009).
Several investigators have correlated increased numbers of activated Treg
cells in the periphery and decidua with successful pregnancies, while a reduced
number of Tregs accompany failed pregnancies (Sasaki, Sakai et al. 2004; Zhu
2005). The inflammatory cytokine IL-17, a product of Th17 cells, was found to
localize in cytotrophoblast and syncytiotrophoblast cells in the deciduas of
unexplained recurrent spontaneous abortions (URSA) and normal early pregnant
women, but IL-17 was significantly higher in the URSA group (Liu, Wu et al.
2011). This finding suggests that Th17 cells may play a role in pregnancy failure.
IL17 levels were also significantly elevated in the peripheral blood of these
patients, providing evidence for a concurrent systemic response (Liu, Wu et al.
2011). Interestingly, progesterone induces the production of several antiinflammatory cytokines, including TGF-β from decidual cells (Nakamura 2009).
Thus, decreased levels of progesterone, which accompany failed pregnancy
(Nakamura 2009), may affect the differentiation of these two cell populations.
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The myriad of contributors to immunological imbalance and consequent
failed pregnancy that may occur during pregnancy are becoming increasingly
evident. However, the complexity confounds the ability to define the causal
relationship between aberrant placental immunology and perturbed pregnancy.
The need for additional study is apparent; yet, the inability to obtain human
tissues at will to conduct these investigations highlights the value of an animal
model.
We have used the FIV- infected cat model to evaluate parameters of
lentivirus-induced placental inflammation. Our previous data suggest a proinflammatory placental microenvironment at early pregnancy in the infected cat,
based on the ratio of pro- to anti-inflammatory cytokines, expression of IL-6
(Scott, Boudreaux et al. 2011), and the likely decreased population of Tregs
(Lockett, Scott et al. 2010). We detected and quantified FoxP3 and RORγexpressing cells in whole placental sections using immunofluorescence confocal
microscopy (Chapter III); yet, the location of these cells in the tissues was
unclear. Therefore, the first objective of this study was to localize the two cell
populations by labeling parallel sections with either FoxP3 or RORγ-specific
antibody and comparing both to a parallel specimen immunolabeled with antirelaxin antibody. As relaxin is produced by trophoblasts, its presence
demarcates the maternal-fetal interface. Both FoxP3 and RORγ colocalized with
relaxin. The second objective was to provide molecular evidence of Treg
function in whole placentas. Thus, the expression of Treg markers or products
were evaluated, including FoxP3, CD134, CXCR4, IL-10, and TGF-β. We report
a significant decrease in TGF-β expression in the infected group, but no other
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differences were detected between the two groups. Finally, we correlated
expression of IL-6 (Scott, Boudreaux et al. 2011)with RORγ.As an enhanced
level of IL-6 is indicative of inflammation, its expression should be inversely
correlated to Treg function and positively correlated with Th17 function. In
control cats the expression of IL-6 and RORγ was positively correlated as
predicted, but this relationship was disrupted in infected animals. Collectively, the
data suggest that FIV-induced immunopathology may include perturbation of
Th17 cell dynamics at early pregnancy.This report supports our prior evidence of
a virus-induced, pro-inflammatory placental microenvironment at early
pregnancy.
Materials and Methods
Animals and Virus
Cats were female, reproductively mature, specific pathogen-free (SPF)
animals (Felis domesticus), obtained from a commercial cattery. Ten cats were
inoculated intravenously with 1 cc a feline plasma pool containing FIV-B-2542 at
approximately 1 x 104 copies per ml; ten cats were uninoculated controls. Whole
blood (15 ml) was collected into Vacutainer® tubes at biweekly to monthly
intervals until delivery of kittens. Serum, plasma, and peripheral blood
leukocytes (PBLs) were collected. Confirmation of infection was performed by
standard PCR and serology (Boudreaux, Lockett et al. 2009). Queens were
allowed to breed naturally with SPF males. Fetuses were delivered by cesarean
section immediately after pregnancies were confirmed by ultrasonography at
week 3-4 gestation (early term). The time of FIV inoculation to delivery ranged
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from approximately 9.5 to 13.5 months (mean 11.14 months) for early-gestation.
Fetal and placental tissues were collected from all animals, snap frozen in liquid
nitrogen, and frozen at -80˚C. Infected animals used were euthanized following
delivery. Control cats were spayed and released for adoption after recovery.
Animal protocols were approved by the Institutional Animal Care and Use
Committee of Mississippi State University. The placental tissues used in this
study are shown in Table 4.1.
Table 4.1

Placental Samples Included in Treg Expression Analysis.
Fetus Number

Queen FIV

Placental FIV Status

Fetus Outcome *

Status
8059A

-

-

V

8059B

-

-

V

8059C

-

-

V

8059D

-

-

V

6108A

-

-

V

6108B

-

-

V

6108C

-

-

V

7824A

-

-

V

7824B

-

-

V

7824C

-

-

V

6062A

+

+

V

6062B

+

+

V

8035A

+

+

V

8035C

+

+

NV

1126A

+

+

V

1126B

+

+

V

5111B

+

+

V

5111C

+

+

NV

0866A

+

+

V

0866B

+

+

NV

*Viable (V), Nonviable (NV)
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Purification of RNA from feline placental tissues and conversion to cDNA
Random sections of tissue were obtained from whole placenta. TRIzol
Reagent (Invitrogen, Carlsbad, CA) was used to purify RNA from these tissues.
RNA was purified from the aqueous phase as described (Scott, Burgess et al.
2008). Concentrations were determined using a NanoDrop 1000 (Thermo
Scientific, Waltham, MA). Purified RNA was reverse transcribed using High
Capacity cDNA kit (Applied Biosystems). Reverse transcription reactions (20ul)
were performed using the following protocol: 25C for 10min, 37C for 120min, 85C
for 5sec.
Quantification of Cytokines and Treg Markers by Real time PCR
Complementary DNA obtained from the High Capacity cDNA reactions
were used in gene expression analysis. Primetime assays (Integrated DNA
Technologie, Coralville, Iowa) were used to evaluate the expression levels of
FoxP3, CD134, CXCR4, IL-10, and TGF-B, along with the housekeeping gene βactin. Primer/probe combinations for use in real time analysis are listed in Table
4.2. Probes for target genes were labeled at the 5’ and 3’ ends with 6carboxyfluorescein (FAM)- and Iowa Black ® FQ, respectively. Simplex
reactions were performed with a target gene and the housekeeping gene using
an ABI thermocycler with the following protocol: Step 1. 50C, 2 min. and 95C,
10min; Step 2. 40 cycles (95C for 15sec and 60C for 1min.). Each reaction well
contained 10ul of the 2X Taqman gene expression master mix, 1 ul of 20X
TaqMan gene expression assay and approximately 6ug of cDNA. For every
placental RNA sample, parallel reactions were run in duplicate on separate
plates for each gene. Serially-diluted, pooled RNA from control cats was used to
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generate a standard curve for simplex reactions.Standard curves were used to
calculate the correction coefficient for each target. Differences in the amount of
template cDNA in each reaction were corrected by the cycle threshold (Ct) value
for B-actin. Comparisons of Treg markers between infected versus uninfected
placentas were analyzed statistically using ANOVA. Correlation analyses were
done using an online Spearman rank correlation calculator
(http://www.wessa.net/rankcorr.wasp). Differences were considered significant
at p≤0.05.
Table 4.2

Primer/Probe Sequences for Prime Time Assays.

Gene

Probe/Primer

Sequence (5’-3’)

β-actin

Probe

/56-FAM/ATG GAG AAG /ZEN/ATC TGG CAC CAC ACC TT/3IABkFQ/

Forward

ATC GAA CAC GGC ATT GTC ACC AAC

Reverse

AGT CAT CTT CTC ACG GTT GGC CTT

Probe

/56-FAM/AGC AAT AAT /ZEN/TCC TGG CGC TAC CTC AGC A/3IABkFQ/

Forward

AGC ACG TGG AGC TGT ACC AGA AAT

Reverse

TCC AGT GAC ATC AAA GGA CAG CCA

Probe

/56-FAM/AGC CTA CAC /ZEN/AAA TGC TTT GTG CGG GT/3IABkFQ/

Forward

GGT TCA CAC GCA TGT TTG CCT TCT

Reverse

ACT CGA ATT CAT CCA CGG TCC ACA

Probe

/56-FAM/AAG CAG AGA /ZEN/TGC ACA CCC ACG CAG GA/3IABkFQ/

Forward

TGC ACA CAG TGC AAC CAG AGA AGT

Reverse

ACA GTC GAC TCC ACG ATC GTA ACC

Probe

/56-FAM/ACT GGC ATA /ZEN/GTG GGC AAT GGA TTG GT/3IABkFQ/

Forward

TGA CTC CAT GAA GGA ACC CTG CTT

Reverse

AGG TCT GCC ACA GAT AGG TGC AAT

Probe

/56-FAM/ACC AGG TCC /ZEN/TTG CTG GAG GAC TTT AA/3IABkFQ/

Forward

TTT CAA ACC AAG GAC GAG CTG CAC

Reverse

AAC TGG ATC ATC TCG GAC AAG GCT

TGF-β

FoxP3

CD134

CXCR4

IL-10
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Localization of Tregs and TH17 cells in Placental Tissues using
Immunohistochemistry (IHC)
An IHC protocol developed by our laboratory for detection of specific cell
populations in frozen feline placentas sections (Scott and Wallace, 2011) was
used to localize Treg and Th17 cells. Rabbit polyclonal antibodies
(abcam,1:500) to FoxP3 and RORγ were used to identify Treg and Th17 cells,
respectively. The maternal-fetal interface was determined using a relaxin
antibody (1:500) (a gift from Dr. Peter Ryan, Mississippi State University,
Department of Animal Science). Parallel sections were stained sequentially for
Relaxin, FoxP3, RORγ, and a universal negative control. Tissues were
inclubated with ready to use secondary antibody, goat anti-rabbit IgG, poly-HRP
(Chemicon International Inc., Temecula, CA.) and developed with 3,3’diaminobenzidine (DAB, Invitrogen). Tissues were counterstained with Mayer
hematoxylin and dehydrated.
Results
Localization of Tregs and Th17 Cells at the Maternal-fetal Interface
Treg and Th17 cells were detected by their dark brown intranuclear
staining. These cells were localized by comparing parallel sections
immunolabeled for relaxin (4.1A), FoxP3 (4.1B), and RORγ (4.1C). A universal
negative control specimen (4.1D) did not label, negating the possibility of nonspecific binding of the secondary antibody.
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A

B

C

D

Figure 4.1

Immunohistochemical Localization of Relaxin, FoxP3, and RORγ at
the Maternal-Fetal Interface of a Representative Early Term
Placental Sample.

Relaxin localized in the placental trophoblast at the maternal-fetal interface (A).
FoxP3 and RORγ co-localized at the maternal-fetal interface (B,C). A universal
negative control was included to assure no nonspecific binding occurred (D).
(20X magnification)
Expression of Treg Markers and Cytokines in Placental Tissues
Real time PCR targeting markers that characterize Treg cells in feline
placentas from control and FIV-infected cats was performed (4.2). TGF-β
expression was significantly decreased (p=0.05) in the infected group at early
pregnancy. Differences in expression between placentas from control and
infected animals did not reach the level of significance for any other
immunomodulator evaluated.
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Figure 4.2

Real time qPCR was used to quantify expression of Treg markers or
products.

FoxP3, CD134, CXCR4, IL10, and TGF-β expression was compared between
control (n=10) and infected (n=10) tissues at early pregnancy. Bars represent
mean Ct values subtracted from a negative endpoint (50-mean Ct), bracketed by
standard errors of the mean. P values were obtained from single factor ANOVA.
Values of p<0.05 were considered significant.
Correlation of RORγ and IL-6 Expression in Placentas
A positive correlation between RORγ and IL-6 was observed in the early
term control group, as predicted (p=0.016) (4.3A). RORγ and IL-6 were neither
positively nor negatively correlated in the infected group, indicating infectioninduced disruption in the expected relationship between IL-6 and Th17 cells
(4.3B).
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A.

B.
Figure 4.3

The expression of IL-6 and RORγ were correlated in control (n=10)
and infected (n=10) placental tissues at early gestation.

The data were analyzed using Spearman Rank Order Correlation. P values
<0.05 were considered significant.
Discussion
Pregnancy requires precise regulation of the placental immune response
for successful fetal development and delivery to occur. The inverse relationship
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between Treg and Th17 cells is essential. Elevated Tregs and reduced Th17
cells are favored early in fetal development and continue throughout most of
pregnancy, promoting an anti-inflammatory environment. TGF-β and IL-6
facilitate the proliferation of Tregs and Th17 cells by activating their intranuclear
transcription factors FoxP3 and RORγ, respectively. In this study, we used
placental tissues from the FIV-infected cat and control animals to begin to
evaluate how these cell populations may be involved in lentivirus-induced
placental inflammation.
Tregs accumulate in the human decidua during early, normal pregnancy
(Guerin, Prins et al. 2009),while Th17 cells are depressed. The ratio of the cells
is often inverted in cases of failed pregnancy or placental infection (Liu, Wu et al.
2011)(Zhang 2011 AJRI) illustrating the relevance of the balance in these cell
populations to pregnancy outcome. As there was no information concerning a
role for Tregs and Th17 cells in the feline placenta, it was important to
demonstrate their presence and location within this tissue. We did so by
comparing parallel sections immunolabeled for expression of FoxP3 and RORγ
to sections labeled for relaxin. Relaxin is a protein hormone produced by
decidual cells that causes cervical ripening, pelvic elasticity, and induction of
labor late in human pregnancy, in part by inducing the expression of key
inflammatory cytokines from decidual cells (Bryant-Greenwood et al. 2007). In
the cat, relaxin is known to be expressed by trophoblasts (Klonisch). Thus,
expression of relaxin can be used to demarcate the maternal-fetal interface. We
found that Tregs and Th17 cells co-localize at the maternal-fetal interface in the
cat.
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The balance of cytokine modulators at the maternal-fetal interface is
critical for successful pregnancy to occur. Proliferation of Tregs depends on the
continuous production of TGF-β, an anti-inflammatory cytokine, by the Treg
population. In this study, a significant decrease in TGF-β in placentas from the
infected group was detected, possibly explaining the decrease in the placental
Treg population in infected cats at early pregnancy that we reported previously
(Lockett, 2010). However, Th17 cells are likewise dependent upon TGF-β to
initiate their differentiation from progenitor T cells. Yet, IL-6 is required to drive
those cells further toward their Th17 phenotype. We previously reported
significantly increased levels of IL-6 expression in early-term placentas (Scott,
Boudreaux et al. 2011). In chapter III, we report a trend toward a positive
correlation between Treg and Th17 populations at early pregnancy in infected
cats (Chapter III), while a negative correlation is the norm. Herein, a positive
correlation of IL-6 and RORγ expression in early, control placentas was shown,
while this expected correlation was perturbed in infected tissues. These data
provide evidence that altered expression of key cytokines may contribute to
Treg/Th17 imbalance in infected animals.
In summary, our data confirm the presence of Treg and Th17 cell
populations at the maternal-fetal interface of feline placentas. A virus-induced
decrease in TGF-β in early-term placentas was evident. Along with our previous
reports of increased IL-6 expression (Scott, 2011) and altered Treg/Th17
populations in early-term placentas from FIV-infected cats (Lockett, 2010; Chap
3), the data support a pro-inflammatory placental microenvironmentat this stage
of pregnancy in FIV-infected queens. Collectively, the data suggest that FIV87

induced immunopathology may include perturbation of Th17 cell dynamics at
early pregnancy. Currently, modulators of Th17 cells are being evaluated in
whole placental tissue to help elucidate the interaction between immune
responses and pregnancy failure.
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CHAPTER V
SUMMARY
The biological similarities of HIV and FIV, the clinical parallels of infection
in their respective species, and the potential for vertical transmission of both
viruses illustrate the value of the FIV-infected cat as a small animal model for HIV
pathogenesis and perinatal transmission. As in HIV-infected women, vertical
transmission of FIV can result in poor pregnancy outcome. Reasons why viral
infection compromise pregnancy are not completely understood, but we suspect
that placental immunopathology associated with viral infection may be a
contributing factor. Thus, we are using the FIV-infected cat to study vertical
transmission and lentivirus-inducedplacental immunopathology.
Maternal hematological and virological factors are known to influence
vertical transmission in HIV-infected women. We hypothesized that similar
parameters would be associated with fetal infection in the cat model. In chapter
II of this dissertation, we reported reduced fecundity and increased fetal loss
during early gestation in the infected group. Viral RNA, but not provirus, was
detected in placentas and fetuses. The CD4:CD8 T cell ratio declined
significantly in the infected group within 3.5 months p.i. However, individual
CD4:CD8 T cells ratios neither positively nor negatively correlated with
pregnancy outcome. Plasma viremia was below detectable limits at all time
points in all cats, but cats were provirus positive and seropositive within four
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weeks p.i. and remained positive throughout the duration of the experiment. Fetal
infection did not directly correlate with reproductive outcome. On an individual
cat basis, neither maternal hematology nor virologycould be correlated with
vertical transmission or reproductive outcome as is evident in HIV-infected
women.
The inability to correlate fetal infection with reproductive outcome
suggests an indirect mechanism of fetal damage, such as virus-induced placental
pathology. We previously reported preliminary evidence for a role for placental
inflammation in compromised pregnancy in the FIV-infected cat (Scott et al.,
2008; Weaver et al., 2005). We hypothesized the placental Treg and Th17 cells
were altered by FIV infection. In chapter III, we quantified the expression of Treg
marker FoxP3 and Th17 marker RORγin placental samples from FIV-infected
and control queens at early and late term gestation by measuring fluorescence
intensity by immunofluorescence confocal microscopy. We detected significantly
higher levels of RORγ in FIV-infected placentas at early pregnancy, indicating
that the viral infection may have caused increased numbers of Th17 cells to be
localized in the placenta at this stage of pregnancy. This result is consistent with
our previous reports of a pro-inflammatory placental microenvironment at this
stage of pregnancy in FIV-infected queens coinciding with an elevated rate of
reproductive failure in this group of cats.
In chapter IV, we showed the localization of Treg and Th17 cells at the
maternal-fetal interface and quantified the expression of Treg modulators FoxP3,
CD134, CXCR4, IL-10, and TGF-β in placental samples from FIV-infected and
control queens at early pregnancy by qPCR. We correlated the expression of IL92

6 and RORγ, used to identify Th17 cells. We detected significantly higher levels
of TGF-β in infected queens, indicating the potential for dysregulation of both
Treg and Th17 cell populations. In control cats the expression of IL-6 and RORγ
was positively correlated as predicted, but this relationship was disrupted in
infected animals.These data indicate that Th17 cell dynamicsare altered in FIVinfected queens, possibly contributing to reproductive failure in this group of cats.
Collectively, the data support a pro-inflammatory placental
microenvironmentat early pregnancy in FIV-infected queens. From a mechanistic
viewpoint, we provide evidence that FIV-induced immunopathology may result
from perturbation of the Treg/Th17 cell balance at early pregnancy. Currently,
laser capture microdissection of both Treg and Th17 cell populations is underway
to quantify expression of immunomodulators specific to those cell populations to
determine the impact of viral infection on their function.These expression profiles
may illuminate the functional effects of viral infection on these immunologicallyimportant placental cell populations.
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APPENDIX A
MEASUREMENT OF GENE EXPRESSION IN REGULATORY T CELLS
MICRODISSECTED FROM PLACENTAL TISSUES
FROM FIV-INFECTED AND CONTROL CATS
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Abstract
Regulatory T cells (Tregs) in the placenta play an essential role in
pregnancy maintenance. In the FIV-infected cat model of mother-to-child
transmission of lentiviruses, infection results in reduced fecundity and increased
reproductive failure. Previous studies using whole placental specimens indicate
that Treg populations may be altered in the FIV-infected cat. Therefore, we
hypothesized that viral infection alters placental Treg function. The objective of
this study was to analyze gene expression from these cells specifically.
Placental tissues were collected from FIV-infected and control cats at week three
(early) and week eight (late) pregnancy, cryosectioned, and labeled for
expression of the Treg marker FoxP3 using immunohistochemistry (IHC). Tregs
were collected from the tissue using laser capture microdissection (LCM), RNA
was isolated and subjected to cDNA synthesis, and cDNA was analyzed by real
time PCRtargeting specific Treg markers and β-actin.We were unable to amplify
any gene product, including β-actin. The data proved that RNA degradation
occurred, likely during tissue manipulation for IHC or exposure to the laser during
LCM.Techniques to preserve the integrity of the RNA during these manipulations
must be developed before this method of Treg gene expression analysis will be
useful. These experiments are currently ongoing.
Introduction
The mechanisms of transplacental transmission and pregnancy
perturbationassociated with lentiviral infections are unclear. Placental
inflammation in HIV-infected women was hypothesized to contribute to
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transplacental transfer as a result of abnormal cytokine expression (Shearer et
al., 1997). Disruption of cytokine expression in placental trophoblasts caused by
the virus may contribute to inflammation of the placenta and transplacental
transfer (Shearer et al., 1997). Immunoregulatory cytokines produced at the
maternal-fetal interface are essential for successful pregnancy(Mellor, 2000).
T regulatory cells (Tregs) are immunosuppressive by the release of
cytokine IL-4, IL-10 and transforming growth factor (TGF-β) inhibiting the
proliferation of T cells by suppression of IL-2 production (Thornton and Shevach,
1998). Several studies have correlated an increased number of activated Tregs
in the periphery and decidua with successful pregnancies, while a reduced
number of Tregs accompanies failed pregnancies (Sasaki et al., 2004; Zhu,
2005).
Feline CD4+CD25+ T cells (feline Tregs) are infected and activated during
acute FIV infection (Mexas et al., 2008), producing higherviral mRNA levels than
CD4+CD25- T cells. During acute FIV infection, these cells remain activated
throughout the course of infection (Mexas et al., 2008). Feline Tregs up-regulate
expression of FoxP3 and TGF-β. Increased levels of FoxP3 mRNA were
detected by intracellular protein expression (Mexas et al., 2008). We localized
Treg cells at the maternal-fetal interface (Chapter IV). In the present study, we
hypothesized that FIV infection in pregnant cats causes altered placental Treg
function,potentially contributing to transplacental transmission of the virus and
damage to the fetus.The objective of this study was to analyze gene expression
from these cells collected from early- and late-term placental tissues from FIVinfected and control cats. Following identification of the cells in cryosectioned
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placentas by IHC, cells were removed from the sections using laser capture
microdissection. RNA was extracted from the cells, subjected to cDNA
synthesis, and analyzed using real time PCR to analyze expression of key Treg
markers. These experiments were unsuccessful due to degradation of RNA.
Materials and Methods
Immunohistochemistry (IHC) for FoxP3 labeling
An IHC protocol developed by our laboratory for detection of specific cell
populations in frozen feline placentas sections (Scott et al., 2011) was modified
and used to label Treg cells (Table A1). Rabbit polyclonal antibodies (abcam,
Cambridge, MA, 1:500) to FoxP3 were used to identify Treg cells. A universal
negative control antibody was used to stain parallel sections. Tissues were
incubated with ready-to-use secondary antibody, goat anti-rabbit IgG, poly-HRP
(Chemicon International Inc., Temecula, CA.) and developed with 3,3’diaminobenzidine (DAB, Invitrogen, Carlsbad, CA). Tissues were counterstained
with Mayer hematoxylin and dehydrated for laser capture microdissection.
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Table A.1 Immunohistochemistry protocol used to stain sections from frozen
feline placental tissue for LCM and RNA extraction.

*0.005 M Tris-HCl + 1% bovine serum albumin
*Diethylpyrocarbonate
*Precautionary measures were taken to ensure RNase free working environment.
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Laser Capture Microdissection
Treg cells from IHC prepared samples were dissected by laser capture
microdissection (Veritas Imaging System, Sunnyvale, CA). Cells were cut and
captured by LCM and extracted onto the surface of the cap (CapSure ™ Macro
LCM Caps, Applied Biosystems, Carlsbad, CA) ( 1). The caps were incubated at
45C for 30min in 50µl of extraction buffer (PicoPure™ RNA Isolation Kit, Applied
Biosystems, Carlsbad, CA) to remove cells. Samples were frozen at -80C until
RNA extractions were performed.

A

B

C

D

Figure A.1

Immunohistochemical staining of FoxP3 in late term placental
samples from a representative control cat, 9746.

FoxP3 + cells localized at the maternal-fetal interface (A). Negative control (B).
FoxP3 + cells marked for dissection (C). Dissected cells collected on a cap (D).
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RNA Extraction and Complementary DNA (cDNA) Synthesis
RNA was extracted from the cells using Pico Pure (Applied Biosystems,
Carlsbad, CA). RNA was converted to cDNA as previously described (Chapter
IV). Concentrations of cDNA were determined using a NanoDrop 1000 (Thermo
Scientific, Waltham, MA).
Agarose Gel Electrophoresis
RNA degradation was determined using a 1% agarose gel in an RNAse
free working environment (http://www.flychip.org.uk/rna_qc.php).
Real time PCR
cDNA was used in real time reactions using Prime Time assays as
previously described in Chapter IV.
Results
Real Time PCR
We were unable to amplify product using primer/probe combinations for
either or target and housekeeping genes ( A2).
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Figure A.2

Amplification curves from gene expression analysis following
conversion of placental RNA to cDNA.

Products from whole placentas are shown in purple. Products from
microdissected cells are shown in yellow. (A. β-actin, B. FoxP3)
Gel Electrophoresis
A comparison of RNA migration on a 1% RNA gel showed intact RNA
from whole placental tissues. RNA extracted from microdissected cells was
below the level of detection( A3).
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Figure A.3

1% agarose gel of RNA extracted from whole tissue (1) and
microdissected cells (2).
Conclusions

The data indicate that RNA degradation occurred, likely during tissue
manipulation for staining and microdissection of the Treg population. There are
several steps in the protocol that may result in RNA degradation. The following
changes in protocol may improve the integrity of isolated RNA: 1) Extended
storage of cells extracted from the cap should be avoided. The isolatedRNA
should be immediately reverse transcribed to cDNA and stored in the more
stable state. The previous protocol did not proceed to RNA extraction until all
dissected cells were collected and stored at -80C. It is possible that RNA
degradation occurred during this longer-term storage. 2) Collecting larger
clusters of cells as opposed to individual cells may increase RNA yield. 3) Using
RNA Later(Qiagen, Valencia, CA) during initial collection of the cells may
improve RNA yield. This product protects the tissue sample from degradation by
RNAses during the storage period. A very similar LCM procedure developed in
our lab (Scott et al., 2011)was used successfully to collect larger sections,
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trophoblast populations, from placental tissues. Therefore, we believe
adjustments to our protocol will allow successful microdissection and gene
expression analyses of Treg popoulations as well. This work is currently
underway.
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